{"meta":{"query_hash":"bea3475d61ff","filters":{"venue":"Seminars in Hematology"},"cohort_total":66,"direct_labels_cover":0,"predictions_cover":66,"exported":66,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/bea3475d61ff","api":"https://metacan.xera.ac/api/v1/cohort?venue=Seminars+in+Hematology"},"results":[{"id":"W1822764283","doi":"10.1053/j.seminhematol.2015.10.006","title":"Factor VIII/factor IX prophylaxis for severe hemophilia","year":2015,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Clotting factor; Factor IX; Intensive care medicine; Surgery; Natural history; Pediatrics; Internal medicine","score_opus":0.09963793976761577,"score_gpt":0.4073807134690391,"score_spread":0.30774277370142333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1822764283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006377764,0.99924004,0.000049314713,0.00013577263,0.00015650482,0.0000040275627,0.000011630444,0.0000034008497,0.00033551164],"genre_scores_gemma":[0.0007787943,0.9982834,0.0001135219,0.00024070409,0.00029329478,0.000005633712,0.000024037683,0.0000010905004,0.00025956144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974984,0.000054956636,0.00006951981,0.00003478469,0.00007135192,0.000019573557],"domain_scores_gemma":[0.99931633,0.00037917375,0.00016252864,0.000015038604,0.000083249506,0.000043698208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007198605,0.00086376467,0.0017858725,0.0024123967,0.00019755971,0.0007636852,0.0008283941,0.00093988207,0.0051307124],"category_scores_gemma":[0.0018228813,0.00023841257,0.0006335069,0.0017261846,0.0003979666,0.0009160396,0.00053769955,0.0014128912,0.0012569956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013982403,0.000051116513,0.000117398406,0.032283835,0.00022926733,0.0001522214,0.00002468808,0.00011619577,0.0005987421,0.0006765309,0.029413188,0.93619704],"study_design_scores_gemma":[0.0003078209,0.00043463887,0.0020024215,0.024781741,0.001991247,0.0034640757,0.0000658983,0.00013473142,0.00073616515,0.0011550162,0.9648899,0.000036317324],"about_ca_topic_score_codex":0.00063570816,"about_ca_topic_score_gemma":0.0017032301,"teacher_disagreement_score":0.0051307124,"about_ca_system_score_codex":0.00040707746,"about_ca_system_score_gemma":0.000983881,"threshold_uncertainty_score":0.017163932},"labels":[],"label_agreement":null},{"id":"W1965374233","doi":"10.1053/shem.2002.33610","title":"Arsenic trioxide: Mechanisms of action","year":2002,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; Buthionine sulfoximine; Cancer research; Retinoic acid; Chemistry; Cellular differentiation; Cell biology; Apoptosis; Glutathione; Biochemistry; Biology; Enzyme","score_opus":0.0371550250045134,"score_gpt":0.32436369209071403,"score_spread":0.28720866708620063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965374233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017244658,0.9960562,0.00062494416,0.0005584808,0.0004441676,0.0000070537612,0.000019688354,0.00002354532,0.0020935494],"genre_scores_gemma":[0.001060917,0.9965127,0.0004234334,0.00020753304,0.00025015604,0.000010076356,0.000023392777,0.0000016862664,0.0015101554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998523,0.000023572522,0.000021232627,0.000028354114,0.000059228656,0.000015348707],"domain_scores_gemma":[0.9998323,0.00005616943,0.00002704658,0.000009454865,0.000052391224,0.000022521668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057605223,0.0013671056,0.0018258196,0.0017025175,0.0004716516,0.0015426296,0.0017347075,0.0017549637,0.002833458],"category_scores_gemma":[0.0003726013,0.00033550346,0.0003536034,0.0024081315,0.0011832673,0.0017038503,0.00070410693,0.0018319723,0.003556789],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017114668,0.00007625898,0.00028726284,0.00870973,0.000080098944,0.00080019166,0.0001505469,0.0007339548,0.012210849,0.0106876185,0.042964082,0.9231282],"study_design_scores_gemma":[0.00001759742,0.000047911766,0.00030637678,0.00053205626,0.000056665296,0.0017152228,0.00010818027,0.000053427375,0.0021033143,0.005263223,0.989781,0.000014992074],"about_ca_topic_score_codex":0.0010972259,"about_ca_topic_score_gemma":0.0021592705,"teacher_disagreement_score":0.002833458,"about_ca_system_score_codex":0.0010578961,"about_ca_system_score_gemma":0.0010196865,"threshold_uncertainty_score":0.009478867},"labels":[],"label_agreement":null},{"id":"W1965880348","doi":"10.1053/j.seminhematol.2011.08.008","title":"Management of Bleeding Complications in the Anticoagulated Patient","year":2011,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Prothrombin complex concentrate; Medicine; Rivaroxaban; PROTHROMBIN COMPLEX; Warfarin; Heparin; Cryoprecipitate; Recombinant factor VIIa; Discovery and development of direct thrombin inhibitors; Apixaban; Fresh frozen plasma; Vasopressin; Anticoagulant; Thrombin; Intensive care medicine; Surgery; Coagulation; Internal medicine; Fibrinogen; Platelet; Atrial fibrillation","score_opus":0.14842644137703917,"score_gpt":0.40198710622155237,"score_spread":0.25356066484451323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965880348","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009859205,0.9994165,0.00006219321,0.00013088669,0.00009235062,0.0000019353836,0.0000054402,0.0000030012652,0.0001891308],"genre_scores_gemma":[0.0010740544,0.99822074,0.00022290979,0.00015237239,0.00021628289,0.0000034031395,0.000017948969,8.438751e-7,0.000091348],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995092,0.00010315093,0.00010987116,0.00007157776,0.00017633644,0.00002985786],"domain_scores_gemma":[0.998976,0.0006168399,0.00022750931,0.000014780775,0.000116079435,0.000048900798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007926067,0.00088818104,0.0025072752,0.0023925833,0.00024602798,0.0012202854,0.0013015982,0.0012819928,0.0017105776],"category_scores_gemma":[0.0024807542,0.00028114114,0.00096315634,0.0020330255,0.00042535106,0.001094859,0.00056432147,0.0019711666,0.0006349546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095080904,0.000075214826,0.0008313951,0.01908904,0.00032035593,0.00048984034,0.000041271946,0.0002557032,0.0002767293,0.00048438268,0.017291768,0.9607491],"study_design_scores_gemma":[0.00046909158,0.0007164081,0.020523023,0.088549465,0.004148087,0.026515659,0.00050756964,0.0010772455,0.0009778574,0.005576381,0.8507566,0.0001825012],"about_ca_topic_score_codex":0.0012725428,"about_ca_topic_score_gemma":0.0024011345,"teacher_disagreement_score":0.0025072752,"about_ca_system_score_codex":0.0004990097,"about_ca_system_score_gemma":0.00096020696,"threshold_uncertainty_score":0.0057224035},"labels":[],"label_agreement":null},{"id":"W1966374618","doi":"10.1053/j.seminhematol.2013.03.012","title":"Innate and Adaptive Immunity in Immune Thrombocytopenia","year":2013,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Canadian Blood Services","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Immunology; Immune thrombocytopenia; Autoimmune hemolytic anemia; Medicine; Autoantibody; Acquired immune system; Immune system; Innate immune system; Platelet; Antibody","score_opus":0.04453795000759843,"score_gpt":0.3429824606397965,"score_spread":0.29844451063219807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966374618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043430995,0.99912506,0.00006501833,0.00015653323,0.00026789552,0.000002292883,0.0000061573114,0.000003338544,0.0003302873],"genre_scores_gemma":[0.00048344402,0.9981135,0.000112976435,0.00021508193,0.0006564898,0.0000048021507,0.000016875641,7.1487614e-7,0.0003960885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998172,0.000032927037,0.000033194025,0.000024965622,0.00006824574,0.00002340265],"domain_scores_gemma":[0.99971634,0.00013433331,0.00004960942,0.000006993571,0.000059261165,0.000033485016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062245445,0.0009707415,0.0018150753,0.0019779925,0.00023639758,0.0011077357,0.00082362193,0.0014074986,0.0036275424],"category_scores_gemma":[0.0007237759,0.00030131763,0.0005040675,0.001773714,0.00059244566,0.0013644262,0.0008320759,0.0020486554,0.001891375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017755247,0.00009853759,0.00017747222,0.016326183,0.000113249516,0.00029531083,0.00003448945,0.0003174906,0.0012406164,0.0017929821,0.047556955,0.93186915],"study_design_scores_gemma":[0.00011503805,0.00018693222,0.0011579682,0.005961742,0.000338006,0.0019759715,0.00006938579,0.00016049934,0.00037161022,0.0021751274,0.9874604,0.000027380851],"about_ca_topic_score_codex":0.0006439003,"about_ca_topic_score_gemma":0.0013366828,"teacher_disagreement_score":0.0036275424,"about_ca_system_score_codex":0.00042432136,"about_ca_system_score_gemma":0.0010892863,"threshold_uncertainty_score":0.012135327},"labels":[],"label_agreement":null},{"id":"W1966474816","doi":"10.1053/j.seminhematol.2005.05.002","title":"Pharmacology of 5-Aza-2′-deoxycytidine (decitabine)","year":2005,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":232,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Deoxycytidine; Azacitidine; Ribonucleotide reductase; Decitabine; Deoxycytidine kinase; Cytidine; Pharmacology; Cytidine deaminase; Mechanism of action; Carmustine; Methyltransferase; Floxuridine; Chemistry; Medicine; Biochemistry; DNA methylation; Enzyme; Methylation; Internal medicine; Etoposide; DNA; Cancer; In vitro; Chemotherapy","score_opus":0.030303076366527598,"score_gpt":0.3697691024252496,"score_spread":0.339466026058722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966474816","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033035616,0.9849808,0.001790627,0.0005817727,0.0007080095,0.00003587164,0.00010027404,0.00007158816,0.008427441],"genre_scores_gemma":[0.02089642,0.96798563,0.0016271553,0.0005830591,0.0003452349,0.000058800266,0.00017500125,0.00000856661,0.008320066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993575,0.000013368951,0.0000073304864,0.000013807225,0.000018946175,0.00001085296],"domain_scores_gemma":[0.99993944,0.000021323442,0.000013300049,0.0000047247636,0.000012274755,0.0000088781735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020847918,0.00061316293,0.000987974,0.00053992175,0.00019657885,0.00043813558,0.0008035417,0.00055673986,0.0026098473],"category_scores_gemma":[0.00018809455,0.00017320426,0.00021153816,0.00051787234,0.00026628663,0.00032462395,0.0002555782,0.001251954,0.0021447234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037223456,0.00015479015,0.00022093469,0.0036481337,0.000049955175,0.00062429113,0.000041860774,0.0006107668,0.046349145,0.0031942404,0.014658228,0.93007547],"study_design_scores_gemma":[0.00011535534,0.00052381464,0.002007018,0.0005159819,0.000116924224,0.0040132343,0.000037205267,0.00022736889,0.03774782,0.0011814622,0.9534892,0.000024810868],"about_ca_topic_score_codex":0.00090051576,"about_ca_topic_score_gemma":0.0025063606,"teacher_disagreement_score":0.0026098473,"about_ca_system_score_codex":0.0006573638,"about_ca_system_score_gemma":0.0004300046,"threshold_uncertainty_score":0.008730829},"labels":[],"label_agreement":null},{"id":"W1968556881","doi":"10.1053/shem.2002.31916","title":"Neutropenia associated with primary immunodeficiency syndromes","year":2002,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Neutropenia; Primary immunodeficiency; Medicine; Human immunodeficiency virus (HIV); Primary (astronomy); Immunology; Intensive care medicine; Internal medicine; Chemotherapy","score_opus":0.02383698202285897,"score_gpt":0.26349506739205486,"score_spread":0.2396580853691959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968556881","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050255767,0.996467,0.0003986027,0.00025687346,0.00062589865,0.0000059175873,0.000012947912,0.000013812311,0.0017163221],"genre_scores_gemma":[0.006795262,0.98799056,0.000571434,0.0006824204,0.0023003186,0.000012036794,0.000052608062,0.0000034912607,0.0015919001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978095,0.00004344144,0.000049843486,0.00003682389,0.00006558004,0.000023438184],"domain_scores_gemma":[0.9995617,0.0002234037,0.000101544276,0.000013190759,0.000059188635,0.000040955274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034722828,0.0010761542,0.0016772896,0.0018317412,0.00022823602,0.00066257553,0.00083647436,0.0009405647,0.0019533974],"category_scores_gemma":[0.0011294311,0.00019838537,0.00031841273,0.0016913596,0.00045188077,0.0007240277,0.00048923533,0.001125125,0.0007430185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016558147,0.00006835345,0.0014335671,0.008322506,0.00009793655,0.008909545,0.00004609293,0.00039667956,0.001641356,0.0015556439,0.036060072,0.9413026],"study_design_scores_gemma":[0.00012074678,0.00023937681,0.008216833,0.0047995667,0.000623009,0.12792829,0.00011600482,0.0003400771,0.0012734497,0.0020777744,0.8542216,0.000043368054],"about_ca_topic_score_codex":0.000549496,"about_ca_topic_score_gemma":0.0014171206,"teacher_disagreement_score":0.0019533974,"about_ca_system_score_codex":0.00036345667,"about_ca_system_score_gemma":0.00066316593,"threshold_uncertainty_score":0.006534755},"labels":[],"label_agreement":null},{"id":"W1970329118","doi":"10.1053/j.seminhematol.2006.01.001","title":"Approach to the Complications of Treatment for Acute Leukemia in the Elderly","year":2006,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Intensive care medicine; Clinical trial; Geriatrics; Acute leukemia; Population; Leukemia; Internal medicine; Psychiatry","score_opus":0.071205159430561,"score_gpt":0.39851493782218644,"score_spread":0.32730977839162545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970329118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000553374,0.9992322,0.00007548946,0.0001911546,0.0001421935,0.0000017933062,0.0000037485693,0.0000033625615,0.00029481447],"genre_scores_gemma":[0.0005623411,0.9985233,0.0001813203,0.00024679065,0.000303489,0.0000032634384,0.000009513206,6.9658495e-7,0.00016934758],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969125,0.000066133034,0.000055238834,0.00004053267,0.00012507595,0.000021725617],"domain_scores_gemma":[0.99928826,0.00036225223,0.00017051131,0.000012357689,0.000112566835,0.000054157463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000746232,0.0010596658,0.0022352429,0.0025653325,0.00038101376,0.0010888505,0.0012509628,0.0013409135,0.0020115739],"category_scores_gemma":[0.001381939,0.0002676119,0.00066899206,0.0022422278,0.0005517367,0.0010832641,0.0006788636,0.002420846,0.00094764703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007117254,0.00007596238,0.000430309,0.0136058945,0.0001528822,0.0005746891,0.00004968274,0.00035130812,0.00036801296,0.0011238221,0.028745499,0.9544507],"study_design_scores_gemma":[0.000103756516,0.00026926203,0.005859617,0.019110763,0.0006597245,0.012345169,0.0002562301,0.00029238572,0.00039003266,0.0032175274,0.9574366,0.000058797687],"about_ca_topic_score_codex":0.001445793,"about_ca_topic_score_gemma":0.0037491198,"teacher_disagreement_score":0.0025653325,"about_ca_system_score_codex":0.00077641243,"about_ca_system_score_gemma":0.0011010817,"threshold_uncertainty_score":0.0067293644},"labels":[],"label_agreement":null},{"id":"W1976309343","doi":"10.1053/j.seminhematol.2005.04.002","title":"Autoimmune Pathogenesis and Autoimmune Hemolytic Anemia","year":2005,"lang":"fi","type":"review","venue":"Seminars in Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canadian Blood Services","funders":"","keywords":"Autoimmune hemolytic anemia; Autoantibody; Immunology; Autoimmunity; Autoimmune disease; Medicine; Pathogenesis; Immune system; Antibody","score_opus":0.01934621137326367,"score_gpt":0.295155161502745,"score_spread":0.27580895012948137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976309343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006501145,0.99912995,0.000046360983,0.00012570209,0.00028908736,0.00000204307,0.0000061466926,0.0000037735178,0.00033197112],"genre_scores_gemma":[0.0005873435,0.9976004,0.000109878965,0.00026262642,0.0009355187,0.000004327649,0.000023314356,8.295681e-7,0.0004758762],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997321,0.000045791407,0.00005359698,0.000036900343,0.00009784478,0.00003375236],"domain_scores_gemma":[0.9992999,0.000328636,0.00015274572,0.000020982166,0.00013197474,0.00006582343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007089738,0.0014463292,0.0025717523,0.004324204,0.0003207756,0.0013147577,0.0012550224,0.0020271393,0.003985564],"category_scores_gemma":[0.0011719626,0.00041783723,0.00060999295,0.004070505,0.00067610474,0.001658748,0.00079949974,0.0016011167,0.0021447183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001715711,0.00010168994,0.0005244618,0.017403232,0.00015505924,0.0011477186,0.00005407422,0.00030407976,0.0011597098,0.0009864237,0.07399112,0.9040008],"study_design_scores_gemma":[0.00010448569,0.00016905267,0.0025747984,0.006370865,0.00051433244,0.0084756715,0.00009011603,0.0001290679,0.00031539792,0.0013250052,0.97989607,0.000035206445],"about_ca_topic_score_codex":0.0011334767,"about_ca_topic_score_gemma":0.0020398498,"teacher_disagreement_score":0.004324204,"about_ca_system_score_codex":0.0004963985,"about_ca_system_score_gemma":0.0011842636,"threshold_uncertainty_score":0.013333023},"labels":[],"label_agreement":null},{"id":"W1981576535","doi":"10.1053/j.seminhematol.2005.11.009","title":"Glanzmann’s Thrombasthenia Treatment: A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII and Other Hemostatic Agents","year":2006,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"Novo Nordisk","keywords":"Medicine; Observational study; Thrombasthenia; Glanzmann's thrombasthenia; Recombinant DNA; Internal medicine; Platelet; Platelet aggregation; Biology; Biochemistry","score_opus":0.29480212281825613,"score_gpt":0.42357246351483446,"score_spread":0.12877034069657833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981576535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007239873,0.9919938,0.00007519662,0.00013799287,0.00005429837,0.000009383514,0.00020155466,0.000002925463,0.00028493215],"genre_scores_gemma":[0.02668786,0.9724175,0.00016313541,0.00014481929,0.000105928826,0.000015519507,0.0003894006,0.0000010833913,0.00007473643],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999286,0.0001713413,0.00014802582,0.00012369458,0.00022898588,0.00004201314],"domain_scores_gemma":[0.99830735,0.00087328913,0.0005168676,0.00003689628,0.00020050952,0.0000650372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095204526,0.00038137444,0.0025340493,0.001204244,0.00011403764,0.00046086372,0.00055881304,0.0005034342,0.00076780806],"category_scores_gemma":[0.0022885054,0.00018758571,0.0010294513,0.0034684518,0.00019024944,0.00041300218,0.00021755252,0.0004548194,0.00020345375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021096556,0.00018512328,0.09112351,0.040368445,0.007941969,0.0010958913,0.00011859319,0.00033170352,0.001419106,0.0004980946,0.018162213,0.8366457],"study_design_scores_gemma":[0.0019547828,0.001505718,0.74260145,0.025071476,0.03196329,0.016091524,0.00042639105,0.00059615175,0.0014321832,0.00087819877,0.17731291,0.00016593261],"about_ca_topic_score_codex":0.0027925358,"about_ca_topic_score_gemma":0.0036576544,"teacher_disagreement_score":0.0027925358,"about_ca_system_score_codex":0.00036848194,"about_ca_system_score_gemma":0.0014744616,"threshold_uncertainty_score":0.00555259},"labels":[],"label_agreement":null},{"id":"W1982513449","doi":"10.1016/s0037-1963(00)90100-8","title":"The use of electron microscopy in the investigation of the ultrastructural morphology of immune thrombocytopenic purpura platelets","year":2000,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immunogold labelling; Platelet; Thrombocytopenic purpura; Ultrastructure; Autoantibody; Pathology; Megakaryocyte; Immunology; Platelet disorder; Electron microscope; Medicine; Biology; Antibody; Cell biology; Haematopoiesis","score_opus":0.0379409118034565,"score_gpt":0.3325956344876394,"score_spread":0.2946547226841829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982513449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033184435,0.99721223,0.0007788918,0.00017929799,0.00017134451,0.0000051953925,0.000009463386,0.000011546926,0.0013001701],"genre_scores_gemma":[0.0015756931,0.9960997,0.0011388998,0.00016627922,0.00017824683,0.000006465503,0.000020816948,0.0000027916776,0.0008111263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977285,0.00004330199,0.000026582547,0.000038720482,0.00009691136,0.000021611417],"domain_scores_gemma":[0.9992367,0.00041311284,0.000061461746,0.00004030241,0.00019707863,0.00005145444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010804649,0.001054988,0.0016169108,0.0039061643,0.00035151385,0.0009806929,0.001226643,0.0014736378,0.0014360388],"category_scores_gemma":[0.0007019302,0.00040882145,0.00043131626,0.0025976088,0.0013895095,0.0020890634,0.00080352946,0.0017380228,0.0020600206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009064813,0.00009843018,0.00056722766,0.010613933,0.000100195655,0.0013515339,0.0001296204,0.00047626448,0.021926992,0.0036599422,0.014846926,0.9461382],"study_design_scores_gemma":[0.000040110765,0.00026205814,0.0070207156,0.0035281356,0.0002245047,0.020170398,0.00028903395,0.0005752206,0.011151623,0.007955111,0.9486785,0.000104551254],"about_ca_topic_score_codex":0.0015302765,"about_ca_topic_score_gemma":0.0017787268,"teacher_disagreement_score":0.0039061643,"about_ca_system_score_codex":0.0007630647,"about_ca_system_score_gemma":0.00051704544,"threshold_uncertainty_score":0.0057141185},"labels":[],"label_agreement":null},{"id":"W1983368362","doi":"10.1016/s0037-1963(00)90108-2","title":"Approach to the investigation and management of immune thrombocytopenic purpura in children","year":2000,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Splenectomy; Thrombocytopenic purpura; Azathioprine; Evans syndrome; Pediatrics; Leukopenia; Refractory (planetary science); Neutropenia; Surgery; Internal medicine; Chemotherapy; Platelet; Anemia; Autoimmune hemolytic anemia; Spleen","score_opus":0.0273705047089919,"score_gpt":0.30672038401509955,"score_spread":0.27934987930610766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983368362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105152736,0.9981988,0.0002499306,0.00045406926,0.00026854844,0.000004869591,0.0000067980372,0.00000863282,0.0007032068],"genre_scores_gemma":[0.0008726129,0.9969536,0.00061998935,0.00053910416,0.0006184545,0.000009276171,0.000021576674,0.000001289183,0.0003640446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960583,0.000086934415,0.000068941255,0.000055776152,0.00015319929,0.000029277015],"domain_scores_gemma":[0.9992919,0.00033413092,0.00011256123,0.00001900714,0.00016660223,0.00007575606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009007637,0.001305501,0.002420908,0.0038831206,0.0004055825,0.0010931534,0.0016146285,0.0017361201,0.0019632801],"category_scores_gemma":[0.0013239476,0.000399655,0.0007352,0.0024971517,0.0008002544,0.0011831141,0.0006866346,0.00409509,0.0017215902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009912157,0.00017151874,0.00079243165,0.009174353,0.00017126507,0.002197784,0.00007458273,0.0005093989,0.00097197894,0.0014385214,0.040394533,0.9440045],"study_design_scores_gemma":[0.00018798615,0.0003263638,0.007105164,0.012891306,0.0005732748,0.03693675,0.00020424667,0.00034530307,0.0007119649,0.003455373,0.9371934,0.000068850044],"about_ca_topic_score_codex":0.0021796406,"about_ca_topic_score_gemma":0.0036661269,"teacher_disagreement_score":0.0038831206,"about_ca_system_score_codex":0.0011074967,"about_ca_system_score_gemma":0.0012388456,"threshold_uncertainty_score":0.008035481},"labels":[],"label_agreement":null},{"id":"W1984993435","doi":"10.1053/j.seminhematol.2011.09.001","title":"Introduction: Practical Issues in Hemostasis and Thrombosis","year":2011,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Coagulopathy; Hemostasis; Medicine; Fulminant hepatic failure; Pancytopenia; Liver transplantation; Liver disease; Hemolysis; Immunology; Internal medicine; Gastroenterology; Transplantation; Bone marrow","score_opus":0.04531681965846391,"score_gpt":0.34237113832058996,"score_spread":0.29705431866212606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984993435","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039592708,0.15537833,0.0069296383,0.4122796,0.3959511,0.00007392191,0.00021762795,0.00021312822,0.028560752],"genre_scores_gemma":[0.004811806,0.06513939,0.007126274,0.30571067,0.56204087,0.00014021508,0.00023570322,0.00019000705,0.054605067],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736685,0.0011729742,0.0002978189,0.00027261899,0.00073087966,0.00015894386],"domain_scores_gemma":[0.99405885,0.003408343,0.0002285937,0.00028523436,0.0015090947,0.0005098793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047716293,0.0014583041,0.0012659717,0.0018596018,0.0018398279,0.0036034868,0.0026961763,0.010951367,0.027436165],"category_scores_gemma":[0.0108921,0.000440499,0.0011150892,0.0012059101,0.0040639513,0.00512361,0.0025861966,0.015858572,0.017093968],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002111339,0.000031221665,0.000060674683,0.00037261465,0.0000059082276,0.00016016797,0.000063125764,0.00004916169,0.000115374896,0.014066758,0.94936776,0.035686105],"study_design_scores_gemma":[0.000017858803,0.000040121504,0.00024262286,0.0005554223,0.000010948501,0.0010114831,0.00007610086,0.00007762706,0.000085102874,0.021313768,0.9765538,0.00001520481],"about_ca_topic_score_codex":0.0009863145,"about_ca_topic_score_gemma":0.0014693135,"teacher_disagreement_score":0.027436165,"about_ca_system_score_codex":0.0017762623,"about_ca_system_score_gemma":0.0017625894,"threshold_uncertainty_score":0.09178311},"labels":[],"label_agreement":null},{"id":"W1989164659","doi":"10.1016/s0037-1963(01)90060-5","title":"Progression of iron overload in sickle cell disease","year":2001,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Liver biopsy; Gastroenterology; Deferoxamine; Cirrhosis; Biopsy; Internal medicine; Hemosiderosis; Chelation therapy; Hemochromatosis; Hepatic fibrosis; Sickle cell anemia; Fibrosis; Liver disease; Ferritin; Serum iron; Surgery; Anemia; Disease; Thalassemia","score_opus":0.006454643550912307,"score_gpt":0.2720284594745214,"score_spread":0.2655738159236091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989164659","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995542,0.0022305388,0.00044212514,0.000072038754,0.000014463906,0.000017450928,0.00017978792,0.000029102459,0.0014725893],"genre_scores_gemma":[0.99774724,0.00071496295,0.000294741,0.000017913013,0.000039045215,0.000011013525,0.00019274032,0.0000051198504,0.0009772258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987435,0.000040430634,0.000012020679,0.000019353558,0.000028473483,0.000025288422],"domain_scores_gemma":[0.99938726,0.000136609,0.00017136896,0.00003117098,0.00011435694,0.0001592051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056162296,0.00020150501,0.0004191861,0.001045861,0.00041363598,0.0005124989,0.00018994021,0.0004293564,0.0016245439],"category_scores_gemma":[0.0012342511,0.00015404106,0.00018417998,0.0004808742,0.00017413989,0.00050450425,0.00025435374,0.00052220863,0.00027961718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018045727,0.0012041492,0.6956104,0.00026293952,0.00014588551,0.005885107,0.0023631135,0.0015807244,0.16391397,0.0014784305,0.0024354935,0.10707413],"study_design_scores_gemma":[0.00014134226,0.0024612648,0.9756808,0.00003131468,0.00010717023,0.0039930674,0.0004872331,0.002174522,0.010647372,0.0011185935,0.0031263644,0.000030802592],"about_ca_topic_score_codex":0.0016841536,"about_ca_topic_score_gemma":0.00097300275,"teacher_disagreement_score":0.0016841536,"about_ca_system_score_codex":0.00024950498,"about_ca_system_score_gemma":0.00028122184,"threshold_uncertainty_score":0.005434692},"labels":[],"label_agreement":null},{"id":"W1989751264","doi":"10.1053/j.seminhematol.2010.11.002","title":"Hypercoagulability in Multiple Myeloma and Its Precursor State, Monoclonal Gammopathy of Undetermined Significance","year":2011,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Medicine; Thalidomide; Lenalidomide; Thrombosis; Dexamethasone; Internal medicine; Venous thrombosis; Hematology; Oncology; Immunology; Monoclonal; Gastroenterology; Monoclonal antibody; Antibody","score_opus":0.08532530873158833,"score_gpt":0.358380231891562,"score_spread":0.27305492315997365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989751264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053175994,0.99959594,0.00003289107,0.00007742663,0.00007199241,0.0000014045564,0.0000057508114,0.0000018223296,0.00015956427],"genre_scores_gemma":[0.00057685614,0.9987883,0.00009569593,0.00010806263,0.00024091014,0.000003118709,0.000020161944,5.2024103e-7,0.0001664373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999835,0.00002520929,0.000037365764,0.000025959265,0.00006238568,0.000014097314],"domain_scores_gemma":[0.9996082,0.00018430002,0.00008711081,0.000009745538,0.0000796938,0.000030965763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005344007,0.0008181757,0.0018903356,0.0028130822,0.00023547573,0.0010605716,0.0007871002,0.0010647039,0.0016726316],"category_scores_gemma":[0.0009710417,0.00032492803,0.00047591416,0.003047464,0.00053573895,0.0012500433,0.00056766917,0.0015605704,0.0010844857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012598338,0.00007693729,0.000515698,0.021216491,0.00017550963,0.0005720355,0.000040559502,0.00027074156,0.0009003012,0.0011955587,0.036071073,0.9388391],"study_design_scores_gemma":[0.00017724765,0.00019798597,0.004839182,0.008504165,0.000812546,0.009360797,0.0001567489,0.00026127795,0.0005931411,0.002919188,0.9721204,0.000057348694],"about_ca_topic_score_codex":0.0017106063,"about_ca_topic_score_gemma":0.0032805202,"teacher_disagreement_score":0.0028130822,"about_ca_system_score_codex":0.0004995967,"about_ca_system_score_gemma":0.0010319612,"threshold_uncertainty_score":0.0055955052},"labels":[],"label_agreement":null},{"id":"W1989751673","doi":"10.1016/s0037-1963(01)90093-9","title":"Developing a novel antithrombotic in the academic environment","year":2001,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Antithrombotic; Intensive care medicine; Thrombosis; SAFER; Surgery; Internal medicine","score_opus":0.14057996142899756,"score_gpt":0.4275915578383973,"score_spread":0.28701159640939977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989751673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012519411,0.99773693,0.00021479175,0.000752248,0.00047670407,0.0000045917427,0.000004352693,0.000007856965,0.0006772049],"genre_scores_gemma":[0.00068999984,0.99741083,0.0003959822,0.00057730934,0.00041316968,0.0000060941334,0.000011474297,0.0000012440183,0.0004939036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939,0.00014332536,0.00009606172,0.00009081585,0.00022079945,0.000059068065],"domain_scores_gemma":[0.99898535,0.00054002384,0.00013764187,0.000027302609,0.0002176761,0.00009195432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019550705,0.001060658,0.002609619,0.002204987,0.0006685975,0.0019708711,0.0013336373,0.0028146477,0.0036504327],"category_scores_gemma":[0.001752914,0.00032416751,0.00067482435,0.003275955,0.0009844326,0.0027662434,0.0008014006,0.0028578355,0.0024583007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015047565,0.00014049326,0.0002869139,0.010150121,0.00011324319,0.0005700797,0.000060557686,0.00019212457,0.0018122616,0.0029308791,0.025271457,0.9583214],"study_design_scores_gemma":[0.00017583587,0.0003872798,0.0013689174,0.0041238074,0.00033358045,0.0038926494,0.00016495958,0.00016892287,0.0013125951,0.0030101398,0.9850264,0.00003496995],"about_ca_topic_score_codex":0.0014282335,"about_ca_topic_score_gemma":0.0031402048,"teacher_disagreement_score":0.0036504327,"about_ca_system_score_codex":0.001012151,"about_ca_system_score_gemma":0.0021095201,"threshold_uncertainty_score":0.012211919},"labels":[],"label_agreement":null},{"id":"W2002857087","doi":"10.1053/j.seminhematol.2012.05.004","title":"The Future of Therapy for Relapsed/Refractory Multiple Myeloma: Emerging Agents and Novel Treatment Strategies","year":2012,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Carfilzomib; Bortezomib; Refractory (planetary science); Panobinostat; Thalidomide; Vorinostat; Oncology; Multiple myeloma; Proteasome inhibitor; Combination therapy; Internal medicine; Ixazomib; Pharmacology; Histone deacetylase","score_opus":0.03592587437793413,"score_gpt":0.34443080829094325,"score_spread":0.3085049339130091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002857087","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023120088,0.9539076,0.0016785464,0.036461454,0.0018114926,0.000018311825,0.00006950918,0.000055517743,0.0036856304],"genre_scores_gemma":[0.024480773,0.9460123,0.0050947797,0.012907463,0.008933319,0.00008810472,0.00014463077,0.000027815755,0.002310888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992718,0.000269577,0.00006848579,0.000093557566,0.00017798012,0.00011860648],"domain_scores_gemma":[0.99818724,0.0010326921,0.00022159077,0.000050718354,0.00029801583,0.00020985697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003879286,0.00072334777,0.0024530466,0.0009096612,0.00066167006,0.003223391,0.0014126464,0.0030896978,0.007749004],"category_scores_gemma":[0.002092644,0.00027688342,0.001227422,0.0007693384,0.0019399168,0.0066858176,0.001319264,0.005688269,0.0019270272],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022813554,0.00077263603,0.0013387725,0.003926435,0.0001889018,0.0008383035,0.00022358829,0.0016620054,0.004321703,0.03097858,0.0615005,0.8919671],"study_design_scores_gemma":[0.0014465641,0.0033856386,0.003938305,0.0045753373,0.0006311118,0.0032775202,0.0009620695,0.0040190406,0.00172045,0.0758298,0.90007573,0.00013840772],"about_ca_topic_score_codex":0.00074371736,"about_ca_topic_score_gemma":0.0022512504,"teacher_disagreement_score":0.007749004,"about_ca_system_score_codex":0.0015297543,"about_ca_system_score_gemma":0.0022678832,"threshold_uncertainty_score":0.025922954},"labels":[],"label_agreement":null},{"id":"W2007148967","doi":"10.1053/shem.2002.35979","title":"Chronic myeloid leukemia: Current therapies and the potential role of farnesyltransferase inhibitors","year":2002,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Busulfan; Imatinib mesylate; Chronic myelogenous leukemia; Transplantation; Immunology; Toxicity; Leukemia; Oncology; Pharmacology; Imatinib; Internal medicine; Hematopoietic stem cell transplantation","score_opus":0.01578019992684772,"score_gpt":0.29008924812173104,"score_spread":0.27430904819488333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007148967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022454764,0.99803156,0.00017429313,0.00039813045,0.0002034466,0.0000046892224,0.000011690015,0.000007830482,0.0009439344],"genre_scores_gemma":[0.0010199707,0.99718213,0.00029070964,0.00036012562,0.00026253934,0.000009180072,0.000029677756,0.0000012564835,0.0008445011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998604,0.000027442795,0.00001977784,0.000023711262,0.00005261301,0.000016115378],"domain_scores_gemma":[0.99976224,0.00012357815,0.000037076097,0.00000768005,0.000042858228,0.000026576838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006879,0.0007859209,0.0016851993,0.0010490428,0.00028052213,0.0008666339,0.0009119535,0.0011735193,0.00344214],"category_scores_gemma":[0.0004912269,0.0002156297,0.0004151725,0.0013600878,0.00043614453,0.0012923662,0.00041403185,0.0016902392,0.0020385464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029440003,0.00012897373,0.00014135239,0.0048670024,0.00007555347,0.00031154798,0.000027657892,0.00045063655,0.0018750281,0.0018198276,0.022678519,0.9673295],"study_design_scores_gemma":[0.00016487742,0.00031062725,0.0010051383,0.0014557723,0.00017024735,0.0018629044,0.000055143595,0.00016035349,0.0008204647,0.001757595,0.99221873,0.000018142684],"about_ca_topic_score_codex":0.00083496573,"about_ca_topic_score_gemma":0.002180576,"teacher_disagreement_score":0.00344214,"about_ca_system_score_codex":0.00049024366,"about_ca_system_score_gemma":0.0007073015,"threshold_uncertainty_score":0.011515081},"labels":[],"label_agreement":null},{"id":"W2014193956","doi":"10.1016/s0037-1963(00)90106-9","title":"Management of idiopathic thrombocytopenic purpura in pregnancy","year":2000,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Hematologist; Pregnancy; Medicine; Thrombocytopenic purpura; Pediatrics; Intensive care medicine; Obstetrics and gynaecology; Multidisciplinary approach; Obstetrics; Disease; Immunology; Internal medicine; Platelet","score_opus":0.0341812540339771,"score_gpt":0.3435668771145537,"score_spread":0.3093856230805766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014193956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015531722,0.9985482,0.00021389383,0.00020810733,0.00022532133,0.0000048576844,0.0000073754773,0.0000090224585,0.0006278481],"genre_scores_gemma":[0.001644299,0.9964395,0.00047159492,0.00037211922,0.0005524143,0.000010423664,0.000032094933,0.0000021555459,0.00047526782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971825,0.00006676524,0.000047448237,0.000039687005,0.00010631018,0.000021515845],"domain_scores_gemma":[0.999559,0.00024978476,0.00008197265,0.0000096696085,0.000060463935,0.000039168903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057750195,0.0009834709,0.0020123522,0.0022796798,0.00026631507,0.0008219648,0.0011800876,0.0011728302,0.0018601913],"category_scores_gemma":[0.0012600003,0.0002702812,0.0005694754,0.0014620571,0.0004290526,0.0008667074,0.000481128,0.0020671033,0.0013047297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097232,0.000092699825,0.00026364517,0.007894521,0.00011080547,0.0012136864,0.000038041606,0.0003813669,0.00064050383,0.0005357983,0.020170797,0.9685609],"study_design_scores_gemma":[0.00032072727,0.00053087017,0.0051989392,0.012375314,0.0007653305,0.029491907,0.00018270132,0.0005963925,0.0009025368,0.0023448893,0.9472223,0.00006813962],"about_ca_topic_score_codex":0.00086105365,"about_ca_topic_score_gemma":0.0015800092,"teacher_disagreement_score":0.0022796798,"about_ca_system_score_codex":0.00044211035,"about_ca_system_score_gemma":0.0005242592,"threshold_uncertainty_score":0.006223023},"labels":[],"label_agreement":null},{"id":"W2014514126","doi":"10.1016/s0037-1963(00)90105-7","title":"Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura","year":2000,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"McMaster University","keywords":"Splenectomy; Medicine; Thrombocytopenic purpura; Surgery; Perioperative; General surgery; Portal vein thrombosis; Thrombosis; Platelet; Internal medicine; Spleen","score_opus":0.03277818716647784,"score_gpt":0.3516762761214303,"score_spread":0.3188980889549525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014514126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005402067,0.9983139,0.00023555306,0.00015990995,0.00016223683,0.000003948106,0.0000073830633,0.000007826447,0.0005691769],"genre_scores_gemma":[0.0049638143,0.99281174,0.00038151824,0.0003465438,0.00069111964,0.000012498875,0.000041300904,0.0000022556978,0.0007492006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998704,0.00003005925,0.000028473858,0.000017367469,0.00004183539,0.000011772046],"domain_scores_gemma":[0.999658,0.00018190585,0.00008758765,0.000010284804,0.000028009517,0.000034252585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038759195,0.00062696036,0.0014812745,0.0015593161,0.00016664069,0.00052985817,0.0005131312,0.0007149063,0.0018304888],"category_scores_gemma":[0.0007845328,0.00022067051,0.00038948932,0.0012138266,0.0004534426,0.0008535315,0.00045091694,0.0011470977,0.00074930827],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002856455,0.000064160355,0.0005037899,0.009438497,0.00012885469,0.0012749921,0.000031718602,0.00024435934,0.0010484507,0.00034052905,0.012008231,0.9746308],"study_design_scores_gemma":[0.00095256633,0.0014612641,0.014423377,0.009229424,0.0014793889,0.04966808,0.0002130142,0.0006166834,0.0020612187,0.001768047,0.9180398,0.00008717226],"about_ca_topic_score_codex":0.0003893857,"about_ca_topic_score_gemma":0.00092934555,"teacher_disagreement_score":0.0018304888,"about_ca_system_score_codex":0.0002217185,"about_ca_system_score_gemma":0.00040886155,"threshold_uncertainty_score":0.0061236024},"labels":[],"label_agreement":null},{"id":"W2018427025","doi":"10.1053/shem.2002.35638","title":"Rare causes of hereditary iron overload","year":2002,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ferroportin; Hemochromatosis; Hereditary hemochromatosis; Transferrin receptor; Transferrin; Oxygen transport; Iron deficiency; Hepcidin; Chemistry; Cell biology; Biology; Biochemistry; Metabolism; Internal medicine; Genetics; Anemia; Medicine; Iron homeostasis; Oxygen","score_opus":0.02479043557468403,"score_gpt":0.30622901794424273,"score_spread":0.2814385823695587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018427025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005526383,0.9971745,0.00044058528,0.00023908401,0.00034455734,0.0000056654926,0.000018391276,0.000021187296,0.00120333],"genre_scores_gemma":[0.003245664,0.99381375,0.0006547279,0.00038859685,0.000891561,0.0000074433297,0.00005460189,0.0000039772635,0.00093956216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978286,0.000040440238,0.00004957257,0.000039135328,0.000065822904,0.00002218025],"domain_scores_gemma":[0.99951506,0.00024294709,0.000095614254,0.000018985256,0.00008372048,0.000043638593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043462717,0.0012081427,0.0021136315,0.003965721,0.0003070526,0.0007953232,0.0011753982,0.0012168058,0.0027694362],"category_scores_gemma":[0.0009779633,0.00029093592,0.00045568755,0.00272145,0.00050179043,0.0012357156,0.000630017,0.0009759092,0.0016278179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009079429,0.00007685179,0.0013575922,0.009329118,0.00013520183,0.008954317,0.000088307774,0.00024862157,0.0014775682,0.0008332086,0.026806587,0.9506019],"study_design_scores_gemma":[0.00010440048,0.00015261566,0.0072734077,0.00572121,0.00078480097,0.14686492,0.00025823654,0.0002478007,0.0014065936,0.0022990254,0.83483064,0.00005633005],"about_ca_topic_score_codex":0.0006364502,"about_ca_topic_score_gemma":0.0012494362,"teacher_disagreement_score":0.003965721,"about_ca_system_score_codex":0.00033133707,"about_ca_system_score_gemma":0.0006692153,"threshold_uncertainty_score":0.009264708},"labels":[],"label_agreement":null},{"id":"W2026485319","doi":"10.1053/j.seminhematol.2003.11.020","title":"Elective orthopedic surgery for hemophilia patients with inhibitors: new opportunities","year":2004,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Orthopedic surgery; Surgery; Factor VIIa; Recombinant factor VIIa; Elective surgery; Orthopedic Procedures; Multidisciplinary team; Internal medicine; Coagulation; Tissue factor","score_opus":0.08087543841097544,"score_gpt":0.35303431887029896,"score_spread":0.2721588804593235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026485319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079065394,0.99906594,0.00008125772,0.00026999484,0.00020789816,0.0000014597737,0.0000037120535,0.0000035191401,0.00028713953],"genre_scores_gemma":[0.0005575668,0.9981654,0.00016672212,0.00034711376,0.00053859304,0.000002811176,0.000013263065,0.0000011327522,0.00020734819],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999684,0.000058975154,0.00004938629,0.000056866258,0.000120591896,0.00003023141],"domain_scores_gemma":[0.9989189,0.0006178709,0.0001453328,0.000020707523,0.00018923363,0.00010805336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010283367,0.0010048873,0.0021795563,0.0022367022,0.00029919675,0.0012560353,0.0010507291,0.0017507268,0.003015259],"category_scores_gemma":[0.0012480678,0.0003339298,0.00077184173,0.002333176,0.00069839373,0.001759281,0.0006146849,0.002354896,0.0012998249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014601144,0.00009272116,0.0004001028,0.010231044,0.00011375287,0.00045526453,0.00004537879,0.00022033596,0.00062075484,0.00073840126,0.03314471,0.95379156],"study_design_scores_gemma":[0.00034723908,0.00047831784,0.005756243,0.013436331,0.0006332973,0.007714857,0.0002831743,0.0002999689,0.00040511278,0.0019150942,0.9686641,0.00006620345],"about_ca_topic_score_codex":0.0009852007,"about_ca_topic_score_gemma":0.0034070977,"teacher_disagreement_score":0.003015259,"about_ca_system_score_codex":0.00052744045,"about_ca_system_score_gemma":0.0010499366,"threshold_uncertainty_score":0.010087013},"labels":[],"label_agreement":null},{"id":"W2027522612","doi":"10.1016/s0037-1963(04)00017-4","title":"Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method*1Proceedings of a special symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12–18, 2003, Birmingham, UK","year":2004,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Recombinant DNA; Thrombosis; Albumin; Internal medicine; Chemistry; Biochemistry","score_opus":0.04672441037902176,"score_gpt":0.3446618231764765,"score_spread":0.2979374127974547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027522612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5311473,0.12461933,0.24956046,0.020795204,0.0155651895,0.0015031872,0.00043444504,0.0009255199,0.055449344],"genre_scores_gemma":[0.6686799,0.05060648,0.21808495,0.0054798955,0.0040648575,0.00032326253,0.0009408207,0.00019497132,0.051624898],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926347,0.00017306174,0.00004315611,0.000108292465,0.00035517875,0.000056878776],"domain_scores_gemma":[0.9996959,0.00005994757,0.00004502519,0.000022058673,0.00008734998,0.00008969354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019233092,0.00029821877,0.00033558233,0.0006220947,0.0002981625,0.00089533755,0.00040934124,0.00064944685,0.0032059862],"category_scores_gemma":[0.00090291415,0.00011492691,0.00049750385,0.00020608991,0.0004759364,0.0006604446,0.00048333002,0.0010250254,0.0006793399],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016409548,0.0010646303,0.0026324585,0.0006413655,0.00008120631,0.00048123312,0.00029546567,0.00048732103,0.33028132,0.01237463,0.017937204,0.63208216],"study_design_scores_gemma":[0.0010896872,0.008422607,0.017608946,0.00021868965,0.0003381693,0.0064505856,0.00015090054,0.0038580592,0.4462929,0.004354133,0.51113087,0.00008440594],"about_ca_topic_score_codex":0.0002654805,"about_ca_topic_score_gemma":0.00048202337,"teacher_disagreement_score":0.0032059862,"about_ca_system_score_codex":0.00045304923,"about_ca_system_score_gemma":0.00066336535,"threshold_uncertainty_score":0.010725081},"labels":[],"label_agreement":null},{"id":"W2034902599","doi":"10.1053/j.seminhematol.2005.11.023","title":"New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management","year":2006,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital","funders":"","keywords":"Medicine; Anticoagulant; Coagulation; Intensive care medicine; Recombinant factor VIIa; Pharmacology; Surgery; Internal medicine","score_opus":0.1019684153150992,"score_gpt":0.39447048605097623,"score_spread":0.29250207073587703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034902599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001117918,0.99888283,0.000104739214,0.00026376854,0.00028892246,0.000002822021,0.0000064675664,0.0000044686067,0.00033410182],"genre_scores_gemma":[0.00096974045,0.9973207,0.00026532562,0.00034314164,0.00080505596,0.0000076048423,0.000017907252,0.0000011265192,0.00026937466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961984,0.000077665514,0.000107734755,0.000050036662,0.00011866498,0.000025978343],"domain_scores_gemma":[0.9990049,0.0005194337,0.00021674241,0.000023711995,0.00016293777,0.00007236217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009704993,0.0010057129,0.0027023533,0.0023888634,0.0002573713,0.0008312434,0.0009507431,0.0012644286,0.002511719],"category_scores_gemma":[0.0018547059,0.00029759647,0.00066694926,0.0025974915,0.0004254129,0.0015717391,0.0004616866,0.002028473,0.0010981268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001472204,0.00012558488,0.00035817694,0.011769385,0.00019060659,0.0006222327,0.000035821125,0.0002817601,0.0006092667,0.00092009996,0.025570368,0.9593695],"study_design_scores_gemma":[0.00028547362,0.00080309674,0.0053735874,0.011994195,0.0012046129,0.012406825,0.0001338594,0.0004162729,0.0007007821,0.0021958763,0.9644274,0.000057961483],"about_ca_topic_score_codex":0.00059702265,"about_ca_topic_score_gemma":0.0019036396,"teacher_disagreement_score":0.0027023533,"about_ca_system_score_codex":0.0004904579,"about_ca_system_score_gemma":0.0010222651,"threshold_uncertainty_score":0.008402526},"labels":[],"label_agreement":null},{"id":"W2055244688","doi":"10.1053/j.seminhematol.2013.09.004","title":"Newly Identified Mechanisms in B-Cell Non-Hodgkin Lymphomas Uncovered by Next-Generation Sequencing","year":2013,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Germinal center; Lymphoma; Biology; Disease; B cell; Molecular genetics; Gene; Molecular pathology; Computational biology; Cancer research; Genetics; Immunology; Medicine; Pathology; Antibody","score_opus":0.06928221153326854,"score_gpt":0.3162576214512335,"score_spread":0.24697540991796496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055244688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065915525,0.99773395,0.0005591625,0.00030010086,0.00014737254,0.000005353423,0.000035378886,0.000014747243,0.00054477487],"genre_scores_gemma":[0.0045365463,0.9931103,0.0011395465,0.00046519507,0.00023397713,0.0000102600525,0.00012021929,0.0000026997848,0.0003811988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978954,0.000032421343,0.000025591491,0.0000485418,0.00007482115,0.000029025881],"domain_scores_gemma":[0.99969816,0.00017715736,0.00004522411,0.000009271118,0.00005227341,0.000017908766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007650302,0.0009070051,0.0013895279,0.001400451,0.00015427817,0.0009543957,0.0009641673,0.00091770507,0.0015456878],"category_scores_gemma":[0.00073428097,0.00025284712,0.00074560824,0.0009969586,0.00045727627,0.0012442565,0.0005397342,0.0012753851,0.0006808547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012419578,0.000061442915,0.0014552467,0.0077471654,0.00025452787,0.00086615357,0.00005206443,0.00069651846,0.0076058106,0.0024186089,0.0122291995,0.9664892],"study_design_scores_gemma":[0.00009980512,0.0002650975,0.011095986,0.0061440705,0.0014625101,0.011413396,0.00020232223,0.0015597846,0.009519745,0.009373088,0.9487593,0.00010490836],"about_ca_topic_score_codex":0.000627822,"about_ca_topic_score_gemma":0.0011111944,"teacher_disagreement_score":0.0015456878,"about_ca_system_score_codex":0.0005187822,"about_ca_system_score_gemma":0.0007902044,"threshold_uncertainty_score":0.0051708817},"labels":[],"label_agreement":null},{"id":"W2056781574","doi":"10.1053/shem.2002.31912","title":"Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias","year":2002,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Congenital Neutropenia; Neutropenia; Medicine; Cyclic neutropenia; Granulocyte colony-stimulating factor; Myeloid leukemia; Myelodysplastic syndromes; Immunology; Myeloid; Bone marrow; Bone marrow failure; Progenitor cell; Internal medicine; Febrile neutropenia; Oncology; Haematopoiesis; Stem cell; Chemotherapy; Biology","score_opus":0.010768200657453372,"score_gpt":0.2639980202678668,"score_spread":0.2532298196104134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056781574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018519622,0.99406886,0.0005581013,0.0010539672,0.00032363867,0.0000034569737,0.000048805316,0.000013252895,0.0020779741],"genre_scores_gemma":[0.017265426,0.97943383,0.0006109327,0.00047948994,0.0009951735,0.000011232866,0.000104601764,0.0000022147212,0.0010970267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997508,0.00007548961,0.000024160347,0.000040941854,0.00009071167,0.00001790076],"domain_scores_gemma":[0.9995448,0.00029428076,0.00006350972,0.00001015027,0.000055849123,0.000031392792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005362549,0.00075350143,0.0016589036,0.00074849004,0.00018096907,0.0005158539,0.00083797466,0.0015080803,0.0023628147],"category_scores_gemma":[0.0014891004,0.00016853122,0.0004229189,0.00079256477,0.0002917175,0.0003978211,0.00029485955,0.00086987,0.0007399614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054589054,0.00010089893,0.01346195,0.004649374,0.00046048715,0.005060847,0.000059629572,0.0010831954,0.001299902,0.004399326,0.02974406,0.93913454],"study_design_scores_gemma":[0.00041495444,0.00096002343,0.068304576,0.006535111,0.0021917191,0.07286452,0.00021939882,0.00092902937,0.0018115973,0.010920736,0.8347606,0.000087628934],"about_ca_topic_score_codex":0.0010182628,"about_ca_topic_score_gemma":0.000945779,"teacher_disagreement_score":0.0023628147,"about_ca_system_score_codex":0.00033082446,"about_ca_system_score_gemma":0.0006436764,"threshold_uncertainty_score":0.00790441},"labels":[],"label_agreement":null},{"id":"W2061216977","doi":"10.1053/j.seminhematol.2005.05.007","title":"Decitabine in Acute Myeloid Leukemia","year":2005,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Decitabine; Medicine; Azacitidine; Oncology; Myelodysplastic syndromes; Myeloid leukemia; Demethylating agent; Internal medicine; Chemotherapy; Tolerability; Epigenetic therapy; Myeloid; DNA methylation; Bone marrow; Adverse effect; Biology","score_opus":0.037108946504880426,"score_gpt":0.3763968879141379,"score_spread":0.33928794140925744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061216977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014799545,0.9983639,0.000058843438,0.00024779423,0.0002940161,0.000005588615,0.000020482406,0.0000060117686,0.00085532194],"genre_scores_gemma":[0.0011417218,0.9970003,0.00012373268,0.00034575895,0.00024710843,0.000008734517,0.00003682872,0.0000011035595,0.001094876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998934,0.00001983558,0.00002508007,0.000016610544,0.000031469455,0.00001361576],"domain_scores_gemma":[0.99978834,0.000078632336,0.00006289525,0.000008373111,0.00003877507,0.00002296795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040709044,0.0007226088,0.0016699503,0.0015282712,0.00018235583,0.0006924971,0.00076297374,0.00076805794,0.004430258],"category_scores_gemma":[0.0006745096,0.00020823006,0.00030570631,0.0015809061,0.00030462432,0.0008881282,0.00056267396,0.001160713,0.0019233767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020480377,0.000051000745,0.00011569901,0.011745793,0.00010008628,0.00019889371,0.000018453515,0.00020221803,0.0012023568,0.0009131233,0.03567835,0.9495693],"study_design_scores_gemma":[0.00011802021,0.00020784607,0.0008127102,0.0033137,0.00031916067,0.0013799034,0.000034706252,0.0000663639,0.0007415314,0.0006452349,0.9923488,0.000012122934],"about_ca_topic_score_codex":0.00083406834,"about_ca_topic_score_gemma":0.0026913583,"teacher_disagreement_score":0.004430258,"about_ca_system_score_codex":0.00060554966,"about_ca_system_score_gemma":0.0008675514,"threshold_uncertainty_score":0.014820695},"labels":[],"label_agreement":null},{"id":"W2066190379","doi":"10.1053/j.seminhematol.2008.03.003","title":"On-Label Versus Off-Label Use of Recombinant Activated Factor VII: A Comprehensive Review of Use in Two Canadian Centers","year":2008,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hamilton Health Sciences; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Off-label use; Recombinant factor VIIa; Factor VIIa; Population; Intensive care medicine; Surgery; Pharmacology; Internal medicine; Environmental health; Tissue factor; Coagulation","score_opus":0.19487772537959036,"score_gpt":0.42204677676511815,"score_spread":0.2271690513855278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066190379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006737549,0.9984145,0.000028457112,0.00018455753,0.000030706302,0.000011873588,0.00009828997,0.0000027822368,0.00055502384],"genre_scores_gemma":[0.0026571879,0.99682164,0.00014464493,0.00017403088,0.000016916374,0.000004940875,0.000066947934,0.0000014446997,0.00011213509],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989686,0.00015159437,0.00017867687,0.0001233018,0.0005029288,0.00007493788],"domain_scores_gemma":[0.9969388,0.0012601999,0.00064067135,0.00003922029,0.00095367315,0.00016733485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021965955,0.0007017058,0.0024539125,0.0042373943,0.00047375675,0.001425818,0.001278671,0.00081602787,0.0021552572],"category_scores_gemma":[0.0034479944,0.0002873446,0.0013065776,0.0077360505,0.00071062765,0.00069411297,0.0004664697,0.00087189017,0.00022350905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065811945,0.000073760064,0.0024820026,0.060079966,0.00082506065,0.00024007726,0.00032120803,0.00020804297,0.0010546198,0.00056443404,0.015601995,0.9178907],"study_design_scores_gemma":[0.0005135764,0.0008507387,0.05151343,0.09776899,0.01112931,0.0030178658,0.0011841322,0.0002258989,0.0021165549,0.00045609736,0.8310359,0.00018745726],"about_ca_topic_score_codex":0.12468249,"about_ca_topic_score_gemma":0.30594504,"teacher_disagreement_score":0.8753175,"about_ca_system_score_codex":0.005779334,"about_ca_system_score_gemma":0.015109263,"threshold_uncertainty_score":0.24791348},"labels":[],"label_agreement":null},{"id":"W2069993664","doi":"10.1053/j.seminhematol.2015.01.002","title":"Emerging Biological Insights and Novel Treatment Strategies in Primary Mediastinal Large B-Cell Lymphoma","year":2015,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; Cancer research; Janus kinase; Computational biology; Biology; Pathology; Immunology","score_opus":0.05155560579263405,"score_gpt":0.34031380600222405,"score_spread":0.28875820020959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069993664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000101737576,0.9991474,0.00007844117,0.0002182619,0.00010906421,0.0000020458258,0.000009949041,0.000003852432,0.00032921162],"genre_scores_gemma":[0.0011001178,0.99793977,0.00016652538,0.00030982154,0.00021319752,0.0000037674165,0.000027401888,9.1170006e-7,0.00023842037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998568,0.000026851709,0.000023656947,0.000023015855,0.000048765567,0.000020928195],"domain_scores_gemma":[0.9997539,0.00012809124,0.00003876416,0.0000060433267,0.000051743027,0.000021572192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053678825,0.0006150942,0.0013824478,0.0014602607,0.00020515588,0.0010452822,0.0007192029,0.0008449,0.0024621906],"category_scores_gemma":[0.0007875718,0.00022943712,0.00047227627,0.0013204664,0.0004546079,0.0012353385,0.0006715319,0.0015898161,0.0010273076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010080459,0.00006698372,0.00031768784,0.013385876,0.000102525795,0.00033730533,0.00004119445,0.0004818956,0.0014203048,0.0023864792,0.025937397,0.95542157],"study_design_scores_gemma":[0.00006965444,0.00015368107,0.0014191574,0.0046261274,0.00031776173,0.0025690575,0.00009094446,0.00025334922,0.0005915031,0.002797473,0.98708284,0.000028436763],"about_ca_topic_score_codex":0.00070442277,"about_ca_topic_score_gemma":0.001728802,"teacher_disagreement_score":0.0024621906,"about_ca_system_score_codex":0.0005210099,"about_ca_system_score_gemma":0.0008050431,"threshold_uncertainty_score":0.0082368255},"labels":[],"label_agreement":null},{"id":"W2075793036","doi":"10.1053/j.seminhematol.2009.03.002","title":"Neutropenic Fever Syndromes in Patients Undergoing Cytotoxic Therapy for Acute Leukemia and Myelodysplastic Syndromes","year":2009,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Leukopenia; Neutropenia; Immunology; Context (archaeology); Myelodysplastic syndromes; Intensive care medicine; Bacteremia; Acute leukemia; Leukemia; Internal medicine; Antibiotics; Chemotherapy; Bone marrow","score_opus":0.03148767241871695,"score_gpt":0.34458563194158026,"score_spread":0.3130979595228633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075793036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004045119,0.99854976,0.000110982175,0.00018470544,0.0001308584,0.00000448837,0.000013674291,0.000005802718,0.00059519906],"genre_scores_gemma":[0.0044716815,0.99416876,0.00031660486,0.00037212094,0.0003307473,0.000010608946,0.000042414253,0.000001102195,0.000285988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978215,0.0000485357,0.0000536809,0.000030534982,0.000065943306,0.000019254372],"domain_scores_gemma":[0.9995192,0.00023383218,0.0001355187,0.0000074677364,0.00006727074,0.00003667387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003573825,0.00069671485,0.00164085,0.0013748661,0.00017451555,0.0005978594,0.0005595864,0.0008008979,0.0011747181],"category_scores_gemma":[0.0013703633,0.00019089595,0.0005051055,0.0012637773,0.00026456153,0.0006249984,0.0004192211,0.0009905334,0.00041787012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012686777,0.000053031254,0.0034024974,0.010522634,0.00015809169,0.0011262207,0.000051719555,0.00020518784,0.00058995245,0.00044413918,0.017494708,0.96582496],"study_design_scores_gemma":[0.0003760775,0.0007180701,0.05381867,0.032270245,0.0025191288,0.042992994,0.0004539468,0.00063461385,0.0010475495,0.0018629167,0.863182,0.00012367716],"about_ca_topic_score_codex":0.001055917,"about_ca_topic_score_gemma":0.003165365,"teacher_disagreement_score":0.00164085,"about_ca_system_score_codex":0.00031198192,"about_ca_system_score_gemma":0.00092169485,"threshold_uncertainty_score":0.0039298534},"labels":[],"label_agreement":null},{"id":"W2077735908","doi":"10.1053/j.seminhematol.2005.12.001","title":"Intensive Exposure to Factor VIII May Be a Risk Factor for Inhibitor Development in Mild Hemophilia A","year":2006,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Risk factor; Medicine; Hematology; Factor (programming language); Factor IX; Internal medicine","score_opus":0.03278960187903925,"score_gpt":0.3211196351652739,"score_spread":0.2883300332862347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077735908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501544,0.0014175526,0.0002921911,0.00025283443,0.000026080339,0.000010375299,0.00004831047,0.0000150598935,0.0029220313],"genre_scores_gemma":[0.9993399,0.00022166711,0.00009470712,0.00002776003,0.000049023132,0.0000016412542,0.000029044748,0.0000019914937,0.00023423678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997918,0.00008137897,0.000019506491,0.000018760747,0.000047612742,0.0000410136],"domain_scores_gemma":[0.998569,0.0005675134,0.00045648564,0.00005291093,0.0000612448,0.0002928314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024174625,0.00022885467,0.0003841073,0.00076453644,0.0003346357,0.0005978725,0.00017634954,0.0005215821,0.0028944928],"category_scores_gemma":[0.0028333378,0.000121484874,0.00029508173,0.00045967606,0.0002870776,0.00027681375,0.00018229359,0.00062109646,0.00025197884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003504734,0.0004796479,0.9392928,0.000106046115,0.00010013814,0.008549507,0.00014284416,0.0001984012,0.008758678,0.0005319826,0.0009144189,0.037420847],"study_design_scores_gemma":[0.000047042406,0.0013160176,0.9798172,0.000025682248,0.00011106159,0.014629469,0.0001394972,0.0005518842,0.0016738005,0.0006011776,0.0010737242,0.000013439998],"about_ca_topic_score_codex":0.0008515672,"about_ca_topic_score_gemma":0.00059078896,"teacher_disagreement_score":0.0028944928,"about_ca_system_score_codex":0.00019405804,"about_ca_system_score_gemma":0.00019466423,"threshold_uncertainty_score":0.009683013},"labels":[],"label_agreement":null},{"id":"W2082076083","doi":"10.1016/s0037-1963(01)90143-x","title":"Use of recombinant factor VIIa (NovoSeven®) in patients with Glanzmann thrombasthenia","year":2001,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada","funders":"","keywords":"Medicine; Thrombasthenia; Recombinant factor VIIa; Glanzmann's thrombasthenia; Platelet transfusion; Surgery; Platelet; Pediatrics; Internal medicine","score_opus":0.04234984807845457,"score_gpt":0.31284503271944925,"score_spread":0.27049518464099465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082076083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008149984,0.99808395,0.00016502074,0.00017589299,0.000101199876,0.000003355659,0.000014717861,0.000008047666,0.0006328703],"genre_scores_gemma":[0.00646584,0.99228925,0.00026218838,0.00029517876,0.00023318516,0.000006603035,0.000060076243,0.0000020291654,0.00038551452],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997813,0.000047696773,0.000041109815,0.00003522236,0.00007847671,0.000016213808],"domain_scores_gemma":[0.9995684,0.0002719908,0.000084670115,0.000010114331,0.00003996178,0.000024809095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004954578,0.0005649291,0.0019699258,0.0009973742,0.0001620948,0.00044680914,0.0007712517,0.00083329383,0.0016306232],"category_scores_gemma":[0.000992721,0.00016421801,0.00073575514,0.0010449876,0.0002312133,0.00048671398,0.00019092711,0.00087244285,0.0008625199],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046537872,0.00010551431,0.001819092,0.009710627,0.0005393079,0.0018289114,0.000038278948,0.00024231139,0.0012779244,0.00031850924,0.012922232,0.9707318],"study_design_scores_gemma":[0.0015714725,0.002422192,0.038552146,0.013315056,0.0065334747,0.0778348,0.00026317374,0.0007260361,0.004587252,0.0017806548,0.85229087,0.00012288199],"about_ca_topic_score_codex":0.0007529376,"about_ca_topic_score_gemma":0.001571924,"teacher_disagreement_score":0.0019699258,"about_ca_system_score_codex":0.0002751369,"about_ca_system_score_gemma":0.0005598939,"threshold_uncertainty_score":0.005455017},"labels":[],"label_agreement":null},{"id":"W2082968048","doi":"10.1053/j.seminhematol.2015.01.012","title":"Summary and Future Directions","year":2015,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Clinical trial; Disease; Medicine; Precision medicine; Intensive care medicine; Medical physics; Bioinformatics; Computational biology; Internal medicine; Biology; Pathology","score_opus":0.03294181224422383,"score_gpt":0.3480487230918615,"score_spread":0.3151069108476377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082968048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007355484,0.9876587,0.00019924212,0.005425208,0.0047995006,0.000016183438,0.00012738476,0.000026933672,0.001673414],"genre_scores_gemma":[0.0009618269,0.98281,0.0004751638,0.0076827114,0.0054724747,0.00004432964,0.00020544084,0.000006261957,0.002341822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915457,0.00023164468,0.00015450062,0.00014673457,0.0001813929,0.00013119902],"domain_scores_gemma":[0.99779224,0.00076580886,0.00040355005,0.000060621966,0.0006532391,0.0003244775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024672013,0.0012169379,0.0028752978,0.0031940935,0.0005348111,0.003032449,0.0014183255,0.0024554795,0.035092156],"category_scores_gemma":[0.004840625,0.00040567646,0.001298875,0.0030262205,0.00081121555,0.0046496512,0.0024875943,0.0034197355,0.009249472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002676902,0.00006842266,0.0002527394,0.033592153,0.00023184382,0.00023795468,0.00010086557,0.0003103305,0.0004768813,0.00508559,0.22506236,0.73431325],"study_design_scores_gemma":[0.0000705439,0.000115741386,0.00044648585,0.014932872,0.00044124603,0.00043308767,0.00014507187,0.00008235683,0.0000905224,0.0037872333,0.9794287,0.000026044308],"about_ca_topic_score_codex":0.0011269335,"about_ca_topic_score_gemma":0.0040240046,"teacher_disagreement_score":0.035092156,"about_ca_system_score_codex":0.001327507,"about_ca_system_score_gemma":0.005179455,"threshold_uncertainty_score":0.117394924},"labels":[],"label_agreement":null},{"id":"W2091003010","doi":"10.1053/j.seminhematol.2004.07.010","title":"Gaucher disease type 1: Revised recommendations on evaluations and monitoring for adult patients","year":2004,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Enzyme replacement therapy; Disease; Glucocerebrosidase; Physical examination; Intensive care medicine; Internal medicine; Pediatrics","score_opus":0.04341008092602514,"score_gpt":0.39245090929559057,"score_spread":0.3490408283695654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091003010","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025956815,0.08792434,0.07229721,0.6637875,0.06014076,0.002618853,0.006317082,0.0027414411,0.078215994],"genre_scores_gemma":[0.15103857,0.08251397,0.36516887,0.28550792,0.037556503,0.007135601,0.01307333,0.0009210391,0.057084206],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99142975,0.0035244508,0.0025717332,0.00031583014,0.0016378375,0.0005203228],"domain_scores_gemma":[0.96853894,0.008416705,0.0022359504,0.0012406309,0.018069398,0.0014982485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010773712,0.001430553,0.002195138,0.002625637,0.0011864223,0.0014798167,0.0032920626,0.008332543,0.003649049],"category_scores_gemma":[0.033999104,0.00066663016,0.0028411746,0.0016606397,0.0010365655,0.001373197,0.0012248596,0.007222574,0.003618172],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008114497,0.0003833211,0.014079988,0.0011558968,0.00019291753,0.0016129975,0.0004037704,0.0015525824,0.0024910625,0.0017708731,0.77595305,0.19959205],"study_design_scores_gemma":[0.000845667,0.0008499016,0.06186607,0.0076496247,0.0012294905,0.009109752,0.0008065326,0.0026775112,0.0050008427,0.0042568804,0.9054977,0.00020983312],"about_ca_topic_score_codex":0.01178214,"about_ca_topic_score_gemma":0.017620625,"teacher_disagreement_score":0.01178214,"about_ca_system_score_codex":0.0019627288,"about_ca_system_score_gemma":0.0048111337,"threshold_uncertainty_score":0.05697757},"labels":[],"label_agreement":null},{"id":"W2091797533","doi":"10.1016/s0037-1963(01)90098-8","title":"Looking forward in the treatment of deep-vein thrombosis","year":2001,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Deep vein; Pulmonary embolism; Thrombosis; Intensive care medicine; Clinical trial; Heparin; Thrombolysis; Low molecular weight heparin; Venous thrombosis; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.043912146771151815,"score_gpt":0.36470863817950033,"score_spread":0.32079649140834854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091797533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004617958,0.9978968,0.00012818868,0.0008278153,0.0006854026,0.0000025843979,0.0000048105676,0.000004769373,0.000403414],"genre_scores_gemma":[0.0004948548,0.99663925,0.00033179158,0.0010932303,0.0010216777,0.000003433252,0.000013069182,0.000001845772,0.00040081827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932015,0.00019306957,0.000105838,0.00009585085,0.00024011404,0.000045013934],"domain_scores_gemma":[0.99894935,0.00056942867,0.00013627672,0.000033956232,0.00021628499,0.00009475773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016419471,0.0011265036,0.003340847,0.002191933,0.00048429644,0.0016856847,0.0019102504,0.0023775187,0.0048534246],"category_scores_gemma":[0.002168054,0.00037139092,0.0011445131,0.0026790192,0.0010143124,0.003179056,0.0007346593,0.0055630757,0.0032818334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014325434,0.00011079396,0.0002991788,0.013473836,0.0001491897,0.0007064594,0.00006613803,0.0003167197,0.00086409366,0.0014733997,0.042102225,0.9402945],"study_design_scores_gemma":[0.00019015481,0.0003444929,0.0023119317,0.012904355,0.00049088855,0.00624572,0.00018611038,0.00018731532,0.00039973407,0.0038682395,0.9728141,0.000056842196],"about_ca_topic_score_codex":0.0013131052,"about_ca_topic_score_gemma":0.0031116756,"teacher_disagreement_score":0.0048534246,"about_ca_system_score_codex":0.0007203621,"about_ca_system_score_gemma":0.0011141022,"threshold_uncertainty_score":0.016236305},"labels":[],"label_agreement":null},{"id":"W2129895042","doi":"10.1016/s0037-1963(01)90120-9","title":"Bacterial contamination of platelet concentrates: Incidence, significance, and prevention","year":2001,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services; Héma-Québec","funders":"","keywords":"Medicine; Sepsis; Incidence (geometry); Platelet; Platelet transfusion; Contamination; Intensive care medicine; Blood transfusion; Transfusion reaction; Blood product; Immunology; Surgery; Biology","score_opus":0.02968836634844066,"score_gpt":0.33418475532151626,"score_spread":0.3044963889730756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129895042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041564996,0.99909484,0.00008050092,0.00014780581,0.00006265975,0.0000024683086,0.000009850991,0.0000031860022,0.00018304538],"genre_scores_gemma":[0.0016274765,0.99792683,0.00013619996,0.00009393007,0.00009649977,0.0000030144372,0.00001521168,5.6403934e-7,0.00010038427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99929595,0.0001165752,0.0001557331,0.00009560004,0.00030344218,0.000032733307],"domain_scores_gemma":[0.9983833,0.0007220461,0.0004357773,0.000032823296,0.0003581736,0.000067961846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009565714,0.00097036327,0.002295662,0.002046568,0.0002130173,0.00096582307,0.000917643,0.0013046415,0.001047885],"category_scores_gemma":[0.0020868478,0.00030917642,0.00060586346,0.0030095277,0.00049711275,0.0009823126,0.00040331561,0.0008714898,0.0007193112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017309752,0.00007094098,0.0038353528,0.014147398,0.0001396292,0.0006707359,0.00008393719,0.000186342,0.001023638,0.00029900897,0.009984919,0.9693849],"study_design_scores_gemma":[0.00018157315,0.0016343548,0.0715219,0.027157545,0.002282716,0.041579187,0.0011633172,0.00073333964,0.0035640746,0.002598016,0.84744155,0.00014249368],"about_ca_topic_score_codex":0.0017772762,"about_ca_topic_score_gemma":0.0029459693,"teacher_disagreement_score":0.002295662,"about_ca_system_score_codex":0.0003335232,"about_ca_system_score_gemma":0.001215528,"threshold_uncertainty_score":0.0050588846},"labels":[],"label_agreement":null},{"id":"W2139834228","doi":"10.1016/s0037-1963(01)90047-2","title":"Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells","year":2001,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University Health Network","funders":"","keywords":"Immunophenotyping; CD34; Enumeration; Apheresis; Stem cell; Flow cytometry; Progenitor cell; Haematopoiesis; Immunology; Biology; Pathology; Cancer research; Medicine; Cell biology; Platelet; Mathematics","score_opus":0.032300018200299374,"score_gpt":0.3132386691130548,"score_spread":0.28093865091275544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139834228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002048503,0.9631061,0.025818944,0.001165296,0.0011665864,0.00008362424,0.00017509154,0.0002730415,0.006162835],"genre_scores_gemma":[0.007365026,0.96366173,0.017601049,0.0012615458,0.0009812339,0.00014241967,0.00045336175,0.00003355485,0.008500011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999172,0.00014967621,0.000063417894,0.00015535571,0.00041255855,0.00004704555],"domain_scores_gemma":[0.99907047,0.00040233266,0.0000907681,0.00006280683,0.00031782803,0.00005585548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017816256,0.0016333159,0.0029214225,0.0037046894,0.00030371462,0.0010618333,0.0026704827,0.0013062261,0.0021476205],"category_scores_gemma":[0.0013188054,0.00043449237,0.00058956887,0.0028330376,0.0011865874,0.0014781598,0.00074748497,0.0020149425,0.0036158073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014319322,0.00013458995,0.0008277258,0.002993773,0.000038669743,0.00015050004,0.000038970138,0.0003525223,0.015841452,0.002345273,0.014513262,0.96262],"study_design_scores_gemma":[0.00007284481,0.0003856582,0.009270209,0.0016195355,0.00021987369,0.007794834,0.00016500366,0.0013890098,0.050871626,0.009901702,0.91819996,0.0001097856],"about_ca_topic_score_codex":0.00073565176,"about_ca_topic_score_gemma":0.00076920685,"teacher_disagreement_score":0.0037046894,"about_ca_system_score_codex":0.00075105863,"about_ca_system_score_gemma":0.00091108767,"threshold_uncertainty_score":0.009422243},"labels":[],"label_agreement":null},{"id":"W2144640698","doi":"10.1053/j.seminhematol.2013.03.007","title":"Understanding the Importance of Using Patient-Reported Outcome Measures in Patients With Immune Thrombocytopenia","year":2013,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Immune thrombocytopenia; Medicine; Intensive care medicine; Patient-reported outcome; Clinical Practice; Disease; Platelet; Quality of life (healthcare); Immunology; Family medicine; Internal medicine","score_opus":0.06738332733023372,"score_gpt":0.2921699711402158,"score_spread":0.2247866438099821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144640698","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8518446,0.036888804,0.06294189,0.02658233,0.0014527465,0.0020482156,0.0031203171,0.00011247618,0.015008592],"genre_scores_gemma":[0.9685081,0.0041461205,0.021801803,0.0023142754,0.0004357839,0.0018258934,0.00069946767,0.000021427522,0.00024721527],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9208268,0.065616995,0.0074098506,0.0013116379,0.004292742,0.0005419154],"domain_scores_gemma":[0.81541365,0.14084388,0.029528258,0.005039685,0.00802554,0.001149001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.086955,0.0006206914,0.0014235969,0.0016661563,0.00063117547,0.003079005,0.0009546098,0.0011224283,0.00075110054],"category_scores_gemma":[0.14649464,0.00026309505,0.0012592576,0.0026757724,0.001407941,0.0036224357,0.0015497751,0.0023593744,0.00019799326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011205093,0.0007799042,0.78072923,0.0027754598,0.0019008671,0.00020658664,0.0033951642,0.00231788,0.0005603346,0.0050743357,0.0026312883,0.19850843],"study_design_scores_gemma":[0.00034029153,0.0057661487,0.9382818,0.004039268,0.0014961138,0.0013984722,0.0048447237,0.009756632,0.0019803746,0.018706633,0.013142569,0.00024682874],"about_ca_topic_score_codex":0.00083004666,"about_ca_topic_score_gemma":0.0013279693,"teacher_disagreement_score":0.086955,"about_ca_system_score_codex":0.0007063386,"about_ca_system_score_gemma":0.0012233608,"threshold_uncertainty_score":0.45986754},"labels":[],"label_agreement":null},{"id":"W2146253957","doi":"10.1053/j.seminhematol.2008.04.005","title":"Misconceptions, Challenges, Uncertainty, and Progress in Guideline Recommendations","year":2008,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Guideline; Grading (engineering); Psychological intervention; Acknowledgement; Medicine; MEDLINE; Management science; Risk analysis (engineering); Psychology; Medical education; Computer science; Nursing; Political science; Engineering","score_opus":0.20085844689566926,"score_gpt":0.47323359137797044,"score_spread":0.27237514448230116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146253957","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011151296,0.011389671,0.01137615,0.9583673,0.0036156361,0.00014074314,0.00012404073,0.000093255585,0.0037419656],"genre_scores_gemma":[0.45553535,0.040017877,0.16273947,0.3282028,0.009585056,0.0012561274,0.00064456195,0.00036523107,0.0016535048],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.55117,0.29554784,0.06433346,0.008290355,0.07508303,0.005575279],"domain_scores_gemma":[0.14580034,0.72542655,0.030587297,0.014893395,0.07441009,0.008882319],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.49709573,0.00090218836,0.0022651798,0.008606348,0.00756435,0.02025798,0.0088169705,0.014217332,0.0023089896],"category_scores_gemma":[0.77079844,0.0024505835,0.0024130107,0.0058874977,0.019424442,0.028381348,0.009251123,0.03517471,0.00080038176],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035626066,0.0006724989,0.04390051,0.00406916,0.0010501496,0.001751798,0.09369308,0.0029392347,0.0006133563,0.07761927,0.23268837,0.54064626],"study_design_scores_gemma":[0.00057584204,0.00041823502,0.021786634,0.049923655,0.001227595,0.0031569854,0.12755288,0.013667395,0.0023246927,0.43190673,0.34641305,0.0010462962],"about_ca_topic_score_codex":0.018067677,"about_ca_topic_score_gemma":0.03297283,"teacher_disagreement_score":0.5029043,"about_ca_system_score_codex":0.015267234,"about_ca_system_score_gemma":0.057137024,"threshold_uncertainty_score":0.6201705},"labels":[],"label_agreement":null},{"id":"W2162413706","doi":"10.1053/j.seminhematol.2011.08.002","title":"A Rational Approach to the Diagnosis and Management of Thrombocytopenia in the Hospitalized Patient","year":2011,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research","keywords":"Antithrombotic; Medicine; Context (archaeology); Intensive care medicine; Hematology; Thrombosis; Platelet transfusion; Internal medicine; Platelet","score_opus":0.053261335839437485,"score_gpt":0.32984950746083536,"score_spread":0.27658817162139787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162413706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024900062,0.99353844,0.0011957951,0.0031359983,0.00044423164,0.000013803353,0.000023151522,0.000026814163,0.001372762],"genre_scores_gemma":[0.002808308,0.990247,0.0030219778,0.0019337467,0.001464938,0.000024613886,0.00007249639,0.0000034094298,0.00042342738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995573,0.00011720998,0.00008504857,0.000050677896,0.0001667557,0.000023059507],"domain_scores_gemma":[0.99929273,0.00036613375,0.00010258741,0.000018832927,0.0001558409,0.00006391338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079096266,0.0012424032,0.0023453215,0.0025486944,0.00042670808,0.001370379,0.0015553508,0.0021306928,0.0016386729],"category_scores_gemma":[0.001964323,0.00027776868,0.00076015363,0.0012892295,0.00066339347,0.0014649371,0.00075473177,0.005215235,0.0011628779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088147484,0.00020241646,0.0013700958,0.006489115,0.00014092082,0.0028204208,0.00007095789,0.0006910094,0.0012782973,0.0037785375,0.045551747,0.9375184],"study_design_scores_gemma":[0.00026135144,0.0004956316,0.015367679,0.035170685,0.0009826075,0.05286956,0.00059471256,0.001782052,0.001879943,0.024319425,0.8660907,0.00018568417],"about_ca_topic_score_codex":0.0011760219,"about_ca_topic_score_gemma":0.0019624366,"teacher_disagreement_score":0.0025486944,"about_ca_system_score_codex":0.00088966964,"about_ca_system_score_gemma":0.0017835245,"threshold_uncertainty_score":0.006455064},"labels":[],"label_agreement":null},{"id":"W2167578606","doi":"10.1053/j.seminhematol.2011.08.003","title":"Pregnancy-Associated Venous Thromboembolism: Prevention and Treatment","year":2011,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Pregnancy; Venous thromboembolism; Observational study; Intensive care medicine; Anticoagulant therapy; Maternal morbidity; MEDLINE; Obstetrics; Thrombosis; Surgery; Internal medicine","score_opus":0.0636973072775359,"score_gpt":0.35054353796027043,"score_spread":0.2868462306827345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167578606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007618368,0.9992101,0.00007312893,0.00021497457,0.00013801924,0.0000027240822,0.000010133826,0.000003799964,0.0002707956],"genre_scores_gemma":[0.00081429345,0.99828017,0.000162353,0.00017390298,0.0003713739,0.000005336957,0.00002113144,8.632762e-7,0.00017053631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966395,0.000063083484,0.000074643074,0.000050231745,0.00012241947,0.000025782896],"domain_scores_gemma":[0.99924266,0.00039931768,0.00017179118,0.00001816153,0.00011773448,0.000050377203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007150011,0.0010278084,0.0022561871,0.0027359857,0.00024981707,0.0008381675,0.0009609877,0.0011590382,0.0025573738],"category_scores_gemma":[0.0021024814,0.0003404204,0.00066088914,0.0020308248,0.00041409637,0.00094367313,0.00047209352,0.0019266173,0.00095318333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006725131,0.00011405214,0.0004546606,0.012913145,0.0001692327,0.00023875835,0.000032568092,0.00032130472,0.00036801948,0.0007453625,0.026586082,0.9579896],"study_design_scores_gemma":[0.00017595773,0.0004764998,0.006556798,0.02399259,0.0017131235,0.0075888257,0.00018077908,0.00055487367,0.0007546454,0.0028382975,0.95509696,0.00007068428],"about_ca_topic_score_codex":0.001437422,"about_ca_topic_score_gemma":0.0030816086,"teacher_disagreement_score":0.0027359857,"about_ca_system_score_codex":0.00053763756,"about_ca_system_score_gemma":0.0013048826,"threshold_uncertainty_score":0.0085552335},"labels":[],"label_agreement":null},{"id":"W22000090","doi":"10.1053/j.seminhematol.2011.08.002","title":"Análisis de la tecnología Bluetooth en la formación de Redes WPAN empleando dispositivos móviles","year":2011,"lang":"en","type":"dissertation","venue":"Seminars in Hematology","topic":"Bluetooth and Wireless Communication Technologies","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Bluetooth; Computer science; Telecommunications; Wireless","score_opus":0.007474931788325727,"score_gpt":0.27787986508313334,"score_spread":0.27040493329480764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W22000090","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.817472,0.00751373,0.12968901,0.0009476311,0.00051383075,0.0006592978,0.0013040695,0.002291933,0.03960851],"genre_scores_gemma":[0.91195273,0.0026854167,0.07288731,0.00018617942,0.0000834873,0.00029128845,0.0006697082,0.00023419083,0.011009757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720985,0.00045104342,0.00018044567,0.00035220885,0.0016389227,0.00016753319],"domain_scores_gemma":[0.9931203,0.003440524,0.0008897085,0.0005980699,0.0018616635,0.00008979061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002177129,0.0007200735,0.0003626663,0.0039113592,0.00041254004,0.0020416288,0.0006919331,0.0008678218,0.0029824732],"category_scores_gemma":[0.011026443,0.00035664902,0.00046901984,0.0023777515,0.0005740293,0.0015679918,0.00053478486,0.0007016319,0.0015600206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006135242,0.00022972537,0.103204735,0.0012312842,0.00020789495,0.001613847,0.0033820183,0.006010789,0.07219722,0.0047413404,0.004854702,0.80171305],"study_design_scores_gemma":[0.00013595054,0.0029220819,0.46662202,0.0015617198,0.0010914671,0.013769878,0.0137926815,0.0773892,0.2219037,0.008353459,0.19208807,0.00036980712],"about_ca_topic_score_codex":0.0017734466,"about_ca_topic_score_gemma":0.002307369,"teacher_disagreement_score":0.0039113592,"about_ca_system_score_codex":0.0005228292,"about_ca_system_score_gemma":0.00036075132,"threshold_uncertainty_score":0.011513948},"labels":[],"label_agreement":null},{"id":"W2287115130","doi":"10.1053/j.seminhematol.2016.01.007","title":"Cord blood versus haploidentical stem cell transplantation for hematological malignancies","year":2016,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Umbilical cord; Stem cell; Hematopoietic stem cell transplantation; Cord blood; Human leukocyte antigen; Transplantation; Graft-versus-host disease; Oncology; Internal medicine; Immunology; Antigen; Biology","score_opus":0.057699326872348765,"score_gpt":0.3461659241887371,"score_spread":0.28846659731638835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287115130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001114736,0.99907446,0.000044586013,0.00016990645,0.00018368603,0.0000021606754,0.000008916387,0.000001810075,0.0004029523],"genre_scores_gemma":[0.0019107639,0.9964904,0.00014416424,0.00058879,0.00044081028,0.0000069775756,0.000027027689,0.0000014037292,0.00038964231],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998796,0.000027757704,0.00002730631,0.000025173946,0.000029811723,0.000010355505],"domain_scores_gemma":[0.99973375,0.00017195544,0.00004846046,0.000005989329,0.000024538993,0.000015207227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005236961,0.0004715983,0.0012528839,0.0009362391,0.00015254694,0.00064324803,0.00063192786,0.0006796988,0.0039279545],"category_scores_gemma":[0.00093303504,0.00011940007,0.00040651884,0.00094786106,0.00042685782,0.00073683355,0.00045972073,0.0011706393,0.0006143276],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021652046,0.000040020837,0.0001449581,0.02060697,0.00016248524,0.00016621589,0.000024691417,0.00014544386,0.0007629135,0.0016211168,0.01900213,0.95710653],"study_design_scores_gemma":[0.00023830804,0.00036842842,0.0014754883,0.015144546,0.0012512184,0.002941965,0.00008192253,0.00009613073,0.0009769268,0.0028403741,0.9745583,0.000026487307],"about_ca_topic_score_codex":0.0003475366,"about_ca_topic_score_gemma":0.00121588,"teacher_disagreement_score":0.0039279545,"about_ca_system_score_codex":0.00035939747,"about_ca_system_score_gemma":0.00066030206,"threshold_uncertainty_score":0.013140261},"labels":[],"label_agreement":null},{"id":"W2316830064","doi":"10.1053/j.seminhematol.2016.04.002","title":"The nonhemostatic immune functions of platelets","year":2016,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Platelet; Megakaryocyte; Inflammation; Hemostasis; Immune system; Immunology; Biology; Cell biology; Platelet activation; Medicine; Haematopoiesis; Stem cell; Internal medicine","score_opus":0.010304592633074516,"score_gpt":0.26673843748480736,"score_spread":0.2564338448517328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316830064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4125669,0.5017563,0.0071824198,0.014505695,0.002145288,0.00009189908,0.00025596045,0.00009543587,0.061400097],"genre_scores_gemma":[0.89991975,0.08229082,0.0023614191,0.00204715,0.003892865,0.000075685995,0.00013886906,0.00002245437,0.0092511065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995578,0.00017956845,0.000024205863,0.000031212352,0.00013724415,0.0000699528],"domain_scores_gemma":[0.99952364,0.00020505798,0.00007365603,0.00005132594,0.00006858659,0.000077714794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057841034,0.00036367032,0.00026738975,0.00049298245,0.00027542008,0.0013166782,0.00043922997,0.0005708013,0.0030440108],"category_scores_gemma":[0.0010776452,0.00011540935,0.00027510937,0.00020731204,0.0008013712,0.0007545667,0.0007320508,0.001167589,0.00044847975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020442435,0.00045601948,0.01683171,0.0022843918,0.00026452076,0.006749205,0.0011282781,0.0005148538,0.30482054,0.065158844,0.017060697,0.58268666],"study_design_scores_gemma":[0.0007363407,0.007831322,0.24831021,0.001548844,0.0007152223,0.051109478,0.0026869187,0.0027032911,0.19220646,0.08705508,0.40499055,0.00010637442],"about_ca_topic_score_codex":0.0001762208,"about_ca_topic_score_gemma":0.00015483952,"teacher_disagreement_score":0.0030440108,"about_ca_system_score_codex":0.00018829173,"about_ca_system_score_gemma":0.0003172068,"threshold_uncertainty_score":0.010183215},"labels":[],"label_agreement":null},{"id":"W2327577791","doi":"10.1053/j.seminhematol.2016.04.007","title":"Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside","year":2016,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Immunology; Platelet; Autoantibody; Pathogenesis; Phagocytosis; Antibody; Immune system; Medicine; Fc receptor; Immunoglobulin G; Autoimmunity; Receptor; Autoimmune disease; Internal medicine","score_opus":0.015778138025187426,"score_gpt":0.2578434897383254,"score_spread":0.24206535171313795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327577791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171837,0.0275699,0.021277124,0.011619624,0.0007605267,0.00019977782,0.0006776387,0.00026110664,0.020450598],"genre_scores_gemma":[0.98285747,0.007813043,0.004115066,0.0009714025,0.00017361993,0.000077077544,0.0003196848,0.000037436206,0.0036351525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994802,0.00015545209,0.000045817254,0.000058689977,0.00013906333,0.00012076881],"domain_scores_gemma":[0.99949336,0.000086585416,0.00016058178,0.00011514589,0.00006437907,0.000079985155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014156738,0.0006231614,0.00044133075,0.0007665882,0.00034745113,0.0014066703,0.00074506877,0.0011804152,0.002550672],"category_scores_gemma":[0.0007482344,0.00023050014,0.0008328116,0.00025440077,0.00083123386,0.0013438495,0.0005708261,0.0026397717,0.0004681069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003081575,0.0004932055,0.0032766876,0.00050676503,0.00022400424,0.0013507685,0.00018560849,0.0009700921,0.90448195,0.043165386,0.0016629676,0.04060099],"study_design_scores_gemma":[0.00077018753,0.0039370977,0.022526098,0.00031137728,0.00053845416,0.0062245238,0.0005703178,0.0057704025,0.88604105,0.021799078,0.051445067,0.0000662647],"about_ca_topic_score_codex":0.00032834095,"about_ca_topic_score_gemma":0.0003851881,"teacher_disagreement_score":0.002550672,"about_ca_system_score_codex":0.0007140988,"about_ca_system_score_gemma":0.0006753268,"threshold_uncertainty_score":0.008532822},"labels":[],"label_agreement":null},{"id":"W2393780027","doi":"10.1053/j.seminhematol.2016.05.009","title":"Nodular lymphocyte-predominant Hodgkin lymphoma","year":2016,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Lymphocyte; Immunology; Pathology","score_opus":0.028077245961957188,"score_gpt":0.33993086760641095,"score_spread":0.31185362164445374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2393780027","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010218282,0.9986596,0.000044960376,0.0001528973,0.00021548591,0.0000046141663,0.00002098997,0.000004963457,0.0007942865],"genre_scores_gemma":[0.0013944724,0.99727434,0.00013434005,0.00039316356,0.00029974044,0.0000059688887,0.000050875096,0.0000011211316,0.00044594542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999795,0.000034843906,0.000054991102,0.00003127489,0.000058818303,0.00002500176],"domain_scores_gemma":[0.9996737,0.00012505922,0.00009134967,0.000009974561,0.00006548988,0.000034282697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037537472,0.00076289196,0.0015826313,0.002482064,0.0002223994,0.00093657,0.00069840107,0.0005384245,0.0043940693],"category_scores_gemma":[0.0009315614,0.00025214537,0.00039315427,0.0025062403,0.00043639762,0.00125303,0.00080650084,0.0010061733,0.0012225151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010960063,0.000042401865,0.00054321095,0.03306472,0.0001729469,0.0005593882,0.000038924987,0.00015781874,0.0008188032,0.00072895,0.041967098,0.9217962],"study_design_scores_gemma":[0.00011103015,0.00012303378,0.0027632846,0.021789405,0.0011133133,0.008087601,0.00014475359,0.00008161732,0.00040412773,0.0013228906,0.9640297,0.000029224788],"about_ca_topic_score_codex":0.00089557166,"about_ca_topic_score_gemma":0.0031821209,"teacher_disagreement_score":0.0043940693,"about_ca_system_score_codex":0.0005802181,"about_ca_system_score_gemma":0.0010055408,"threshold_uncertainty_score":0.0146996975},"labels":[],"label_agreement":null},{"id":"W2404321413","doi":"10.1053/j.seminhematol.2016.05.002","title":"Hodgkin lymphoma in the elderly, pregnant, and HIV-infected","year":2016,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Vinblastine; Chemotherapy; Lymphoma; Intensive care medicine; Pregnancy; Drug; Chemoimmunotherapy; Disease; Human immunodeficiency virus (HIV); Oncology; Internal medicine; Surgery; Pediatrics; Immunology; Rituximab; Pharmacology","score_opus":0.02641870394568633,"score_gpt":0.32737695359137803,"score_spread":0.3009582496456917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404321413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012207143,0.9993586,0.000017150243,0.00013405735,0.00008208598,0.0000012869626,0.000006435685,0.0000015538485,0.00027675234],"genre_scores_gemma":[0.0011061946,0.99838114,0.000044165106,0.00016448152,0.0001734624,0.0000017961604,0.000010062127,3.5058565e-7,0.00011838667],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99985516,0.00003125328,0.00003269698,0.00002281742,0.00004272505,0.000015407604],"domain_scores_gemma":[0.999637,0.00020259438,0.000085138694,0.0000060348166,0.000040442937,0.000028904671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000319836,0.00055882393,0.0012703066,0.001760546,0.00023406418,0.00079247344,0.00059551204,0.0006930065,0.0018048597],"category_scores_gemma":[0.0009234498,0.00022135729,0.0003815257,0.0016745987,0.00036412966,0.0009431869,0.00056801364,0.001065804,0.00042088045],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009475518,0.00006284271,0.0017247187,0.022198757,0.00014212709,0.00084263313,0.00008615201,0.00016712553,0.00042965024,0.0007634126,0.027150318,0.94633746],"study_design_scores_gemma":[0.00010916779,0.00021694093,0.01523455,0.04124115,0.0012651952,0.025094045,0.00052835303,0.00022023308,0.00041867135,0.0022215047,0.913383,0.000067309586],"about_ca_topic_score_codex":0.0019306798,"about_ca_topic_score_gemma":0.005478742,"teacher_disagreement_score":0.0019306798,"about_ca_system_score_codex":0.00041428435,"about_ca_system_score_gemma":0.0008295327,"threshold_uncertainty_score":0.0060378313},"labels":[],"label_agreement":null},{"id":"W2790687822","doi":"10.1053/j.seminhematol.2018.03.002","title":"Circulating Tumour DNA for Detecting Minimal Residual Disease in Multiple Myeloma","year":2018,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Minimal residual disease; Multiple myeloma; Bone marrow; DNA; Somatic cell; Cell-free fetal DNA; DNA sequencing; Medicine; Circulating tumor DNA; Cancer research; Computational biology; Biology; Immunology; Internal medicine; Cancer; Gene; Genetics","score_opus":0.08299426955755611,"score_gpt":0.38579050127562864,"score_spread":0.3027962317180725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790687822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010726288,0.99855953,0.00022001508,0.00026104596,0.0001571224,0.000004822907,0.000013962121,0.000008183552,0.00066796126],"genre_scores_gemma":[0.0011017149,0.9977653,0.00035551703,0.00023039151,0.00016474543,0.000007699898,0.000030294634,0.0000021761477,0.00034220974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997098,0.000056531826,0.000041351755,0.00004605939,0.00012728252,0.000018992288],"domain_scores_gemma":[0.99942076,0.0003294578,0.000078829245,0.00001638151,0.00012470367,0.000029859146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008647961,0.0006591282,0.0012898835,0.003188975,0.00021408567,0.0010525169,0.00089364656,0.0012715905,0.0022303774],"category_scores_gemma":[0.0013081142,0.00027104892,0.00057533756,0.0018133043,0.0006832148,0.0012729423,0.0006912648,0.001991535,0.0017094543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000610908,0.000053619875,0.0003910869,0.013844247,0.00009879562,0.0002666724,0.00006376098,0.0002451426,0.0021839284,0.0027470675,0.018323971,0.9617207],"study_design_scores_gemma":[0.000020790207,0.00012614814,0.0017449389,0.0066786064,0.00021582338,0.0043712887,0.00010084163,0.00019823396,0.0018737885,0.0027783215,0.98185086,0.00004025113],"about_ca_topic_score_codex":0.00097511074,"about_ca_topic_score_gemma":0.0014035231,"teacher_disagreement_score":0.003188975,"about_ca_system_score_codex":0.00054379326,"about_ca_system_score_gemma":0.0008573238,"threshold_uncertainty_score":0.007461369},"labels":[],"label_agreement":null},{"id":"W2800767974","doi":"10.1053/j.seminhematol.2018.04.011","title":"Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease","year":2018,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Busulfan; Alemtuzumab; Transplantation; Total body irradiation; Internal medicine; Regimen; Immunosuppression; Oncology; Hematopoietic stem cell transplantation; Fludarabine; Cyclophosphamide; Immunology; Chemotherapy","score_opus":0.02253164265541818,"score_gpt":0.29980091613613336,"score_spread":0.2772692734807152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800767974","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46692726,0.40713155,0.039157577,0.007729379,0.0016525715,0.001187859,0.0012283381,0.0011698081,0.07381574],"genre_scores_gemma":[0.8881977,0.077800155,0.010860258,0.0033393507,0.0013248178,0.00047894995,0.0016962584,0.000052768948,0.016249843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993086,0.00001572301,0.0000058183186,0.000013860298,0.00002363894,0.000010114835],"domain_scores_gemma":[0.9999676,0.0000049712903,0.000009473258,0.0000037925768,0.000003268648,0.000011006057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024589596,0.00022093704,0.00020064782,0.00027891347,0.00028918264,0.00019178208,0.0002452738,0.00023469256,0.0037479477],"category_scores_gemma":[0.00014895434,0.000041251915,0.0001992365,0.00019915578,0.00022155789,0.00020365094,0.00027603866,0.00049259915,0.0008139539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015364782,0.0013329996,0.006327326,0.0023002117,0.00011948788,0.0022458176,0.00026115382,0.0009021504,0.051085915,0.007383684,0.024794936,0.9017098],"study_design_scores_gemma":[0.0029181517,0.017736753,0.11204076,0.003315985,0.0006673702,0.0747759,0.00029881086,0.0030871467,0.085309595,0.019930841,0.67980814,0.000110623994],"about_ca_topic_score_codex":0.00024374058,"about_ca_topic_score_gemma":0.0005223699,"teacher_disagreement_score":0.0037479477,"about_ca_system_score_codex":0.00023818696,"about_ca_system_score_gemma":0.00031342756,"threshold_uncertainty_score":0.012538135},"labels":[],"label_agreement":null},{"id":"W2806076094","doi":"10.1053/j.seminhematol.2018.05.001","title":"Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options","year":2018,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Philadelphia chromosome; Minimal residual disease; Medicine; Chemotherapy; Acute lymphocytic leukemia; Fusion gene; Disease; Oncology; Cancer research; Internal medicine; Immunology; Gene; Leukemia; Bioinformatics; Lymphoblastic Leukemia; Chromosomal translocation; Biology; Genetics","score_opus":0.04204023358257165,"score_gpt":0.379314004845992,"score_spread":0.33727377126342034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806076094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007740171,0.99917597,0.000047562047,0.00025910075,0.000116851916,0.0000021671253,0.000016941181,0.0000034618938,0.00030062374],"genre_scores_gemma":[0.0004739525,0.9988937,0.00010931013,0.00021612961,0.00018105417,0.0000024867945,0.000027742608,5.5902876e-7,0.0000951057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997583,0.00004571838,0.000057091216,0.00004254604,0.000073500625,0.00002276943],"domain_scores_gemma":[0.9992299,0.0004399524,0.00013505247,0.000015447846,0.00012500917,0.00005465279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006866555,0.0007201387,0.0014982668,0.0033459442,0.00027623848,0.0010983946,0.001083164,0.0009515328,0.0025285652],"category_scores_gemma":[0.0016177293,0.00026572766,0.00052293786,0.0035240548,0.0005269653,0.0014383045,0.000688361,0.0016215553,0.0009569095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115095325,0.00005577985,0.00078901614,0.025350558,0.00014543976,0.0011057211,0.00010339359,0.00036872522,0.0013675648,0.0025631525,0.054665513,0.9133701],"study_design_scores_gemma":[0.000034929002,0.00008703713,0.0020256261,0.01027141,0.00038553806,0.010498487,0.00017490773,0.00010572169,0.00029925653,0.0020302213,0.97404873,0.000038225095],"about_ca_topic_score_codex":0.0011104515,"about_ca_topic_score_gemma":0.0022405686,"teacher_disagreement_score":0.0033459442,"about_ca_system_score_codex":0.00065902807,"about_ca_system_score_gemma":0.001533891,"threshold_uncertainty_score":0.008458912},"labels":[],"label_agreement":null},{"id":"W3099890097","doi":"10.1053/j.seminhematol.2020.11.006","title":"Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity","year":2020,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Epigenetics; Immunotherapy; Biology; Immune system; Chimeric antigen receptor; Cytotoxic T cell; Immunology; Gene delivery; Cancer research; Cancer immunotherapy; Genetic enhancement; Gene; Genetics","score_opus":0.040520900348912564,"score_gpt":0.33916994809733997,"score_spread":0.2986490477484274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099890097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945155,0.00063846103,0.0026898263,0.000085635824,0.00006103417,0.000058363483,0.00026107105,0.00008749973,0.0016026129],"genre_scores_gemma":[0.99760747,0.0001607049,0.0005879443,0.000021177784,0.0000045231113,0.000022350458,0.0001743612,0.000012313185,0.0014091257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988043,0.000017003482,0.000009887718,0.000026504602,0.000025988633,0.00004014487],"domain_scores_gemma":[0.9999504,0.00001276781,0.0000073564224,0.000013356964,0.0000062912613,0.000009790466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001497837,0.00016521693,0.0002594747,0.0001056395,0.00012863835,0.00029492928,0.00015760283,0.0001786436,0.004580169],"category_scores_gemma":[0.00012653659,0.00010812243,0.00020442094,0.00007776062,0.00016589636,0.0001055537,0.00016756852,0.0005619006,0.0006070348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021407964,0.00007842168,0.00017193549,0.00001939622,0.0000055758765,0.00002689285,0.000012130798,0.00016977105,0.99672395,0.000120357574,0.000069786554,0.0023876869],"study_design_scores_gemma":[0.00006223777,0.00050137646,0.001926325,0.0000030547708,0.000023266095,0.0001696993,0.000018789167,0.00068835466,0.99446964,0.00004396146,0.0020909323,0.0000024583678],"about_ca_topic_score_codex":0.00031574952,"about_ca_topic_score_gemma":0.0006618191,"teacher_disagreement_score":0.004580169,"about_ca_system_score_codex":0.00020590903,"about_ca_system_score_gemma":0.00023377445,"threshold_uncertainty_score":0.015322208},"labels":[],"label_agreement":null},{"id":"W3176840052","doi":"10.1053/j.seminhematol.2013.03.005","title":"Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia","year":2013,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"Romiplostim; Eltrombopag; Thrombopoietin; Medicine; Thrombopoiesis; Megakaryocyte; Thrombopoietin receptor; Platelet; Internal medicine; Receptor; Pharmacology; Immunology; Immune thrombocytopenia; Progenitor cell; Biology; Haematopoiesis","score_opus":0.03126110105261095,"score_gpt":0.3323598911443993,"score_spread":0.30109879009178836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176840052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008926417,0.9988538,0.00007135966,0.0001751901,0.00019257852,0.0000037232192,0.000011283225,0.0000046816194,0.0005981316],"genre_scores_gemma":[0.0010094335,0.99752694,0.00015656375,0.0003391583,0.00039005285,0.000008066665,0.000022429833,0.0000013015872,0.00054601626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984837,0.000027949203,0.000036268535,0.00002155459,0.00005046214,0.000015513868],"domain_scores_gemma":[0.99962723,0.0001951466,0.0000845044,0.00000852349,0.000051692674,0.00003292072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046307963,0.0007864285,0.0016547889,0.0021311967,0.00019484917,0.00082723686,0.00067699933,0.0010106277,0.004384511],"category_scores_gemma":[0.00087223493,0.00028309927,0.00048820092,0.0017839719,0.00038033025,0.00089246465,0.000566557,0.0016524618,0.001573519],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013087243,0.000072301234,0.000111075926,0.014723515,0.00014141726,0.0002635087,0.000024114517,0.00020670734,0.0007961905,0.00096381514,0.033781912,0.94878453],"study_design_scores_gemma":[0.000204482,0.00028934184,0.0014442339,0.008122631,0.0008216306,0.0035075967,0.000057553054,0.00019539292,0.0006214284,0.0012400354,0.98346496,0.000030693674],"about_ca_topic_score_codex":0.0005658479,"about_ca_topic_score_gemma":0.0019293067,"teacher_disagreement_score":0.004384511,"about_ca_system_score_codex":0.00038754262,"about_ca_system_score_gemma":0.00075350143,"threshold_uncertainty_score":0.01466769},"labels":[],"label_agreement":null},{"id":"W4210915581","doi":"10.1053/j.seminhematol.2022.02.002","title":"Epidemiology of VITT","year":2022,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Incidence (geometry); Thrombosis; Epidemiology; Population; Immunology; Intensive care medicine; Internal medicine","score_opus":0.05389841844282222,"score_gpt":0.3471122796952229,"score_spread":0.2932138612524007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210915581","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575293,0.010577596,0.0012965597,0.0019100113,0.00018881794,0.00008701639,0.011054852,0.0001163267,0.017239586],"genre_scores_gemma":[0.99312675,0.002048053,0.00027381856,0.0002502083,0.000101700556,0.000026157153,0.0024565693,0.000016412589,0.0017003231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864036,0.00030213577,0.00023277788,0.0003608747,0.00024195839,0.00022194565],"domain_scores_gemma":[0.9971143,0.00039957205,0.0014639718,0.00023504843,0.0003178477,0.00046931408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000615573,0.00018539678,0.00036405816,0.0031800368,0.0004941513,0.0012990878,0.0005577546,0.0006418493,0.007893594],"category_scores_gemma":[0.0040844176,0.00034155903,0.0006804901,0.0044296817,0.00039666783,0.0007450439,0.00067543815,0.0015361038,0.0007198025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048081693,0.000040906496,0.9931323,0.000040254676,0.00008238837,0.00020336939,0.0000660352,0.000075565826,0.00010684821,0.00043658365,0.0010165453,0.004751088],"study_design_scores_gemma":[0.0000074602917,0.00009847412,0.9922954,0.000113513604,0.000038632184,0.0028955648,0.00033401133,0.00036378973,0.000078255434,0.00032318273,0.0034398404,0.000011779363],"about_ca_topic_score_codex":0.009765917,"about_ca_topic_score_gemma":0.00411773,"teacher_disagreement_score":0.009765917,"about_ca_system_score_codex":0.0007862422,"about_ca_system_score_gemma":0.00087123533,"threshold_uncertainty_score":0.026406705},"labels":[],"label_agreement":null},{"id":"W4212938842","doi":"10.1053/j.seminhematol.2022.02.005","title":"Platelet-activating anti-PF4 disorders: An overview","year":2022,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Platelet; Medicine; Platelet factor 4; Pharmacology; Immunology","score_opus":0.16350604972570218,"score_gpt":0.42124012624467927,"score_spread":0.25773407651897706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212938842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009205043,0.9951603,0.00036136666,0.0006725603,0.00038745865,0.000009856991,0.000067832254,0.000028874656,0.0023912913],"genre_scores_gemma":[0.003826599,0.99282515,0.0005781856,0.00059761544,0.00093907345,0.000014945223,0.00020355443,0.000004962326,0.00100999],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998772,0.000020363505,0.000027495911,0.000022990174,0.000033284014,0.000018606952],"domain_scores_gemma":[0.9998349,0.00007030262,0.000029153509,0.0000041159233,0.000034705743,0.000026764556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020474104,0.0008067187,0.00072506344,0.0027358544,0.00020184979,0.00069068465,0.00038537156,0.0007011239,0.0036034507],"category_scores_gemma":[0.00038819114,0.0001792996,0.00041256208,0.0016616628,0.00019549417,0.00091979204,0.0003807545,0.0010115553,0.0015017814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014314303,0.00011477365,0.0021548104,0.011715221,0.00017128905,0.0021453924,0.00013627394,0.00037177018,0.002384382,0.002357538,0.06134735,0.9169581],"study_design_scores_gemma":[0.000026162068,0.00017593427,0.004950162,0.0039030805,0.00025067807,0.022776442,0.00011823309,0.00018328198,0.00049927895,0.0018619677,0.965229,0.00002577022],"about_ca_topic_score_codex":0.00073916285,"about_ca_topic_score_gemma":0.0007604985,"teacher_disagreement_score":0.0036034507,"about_ca_system_score_codex":0.00034957405,"about_ca_system_score_gemma":0.00061320415,"threshold_uncertainty_score":0.012054741},"labels":[],"label_agreement":null},{"id":"W4220741413","doi":"10.1053/j.seminhematol.2022.03.002","title":"Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)","year":2022,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; Immunology; Immune system; Immune thrombocytopenia; Hematology; Platelet; Thrombotic thrombocytopenic purpura; Intensive care medicine","score_opus":0.1030270400509977,"score_gpt":0.38560887438270375,"score_spread":0.282581834331706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220741413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002518425,0.9984775,0.00012259246,0.00020784252,0.00014951958,0.0000048237343,0.000009777089,0.000008166236,0.00076779723],"genre_scores_gemma":[0.0024590024,0.99640685,0.00018927707,0.00033009343,0.00024177137,0.00000861103,0.000034034496,0.000001603565,0.00032878987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998692,0.000028263345,0.000019710344,0.000021826603,0.000045423003,0.000015637315],"domain_scores_gemma":[0.9998596,0.0000715625,0.000026795533,0.000004520733,0.000024095094,0.00001348337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027684358,0.00053431076,0.0006952573,0.0013434611,0.0001880838,0.000452065,0.0005458247,0.0008714272,0.0013651099],"category_scores_gemma":[0.0005810692,0.0001081481,0.00041816258,0.00085663906,0.00025687463,0.00048089505,0.0003954651,0.0012050787,0.0006578599],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060728566,0.00006514373,0.00023041909,0.0104327435,0.000105338426,0.00046863602,0.00004331466,0.00025159362,0.001140853,0.0012678563,0.022944342,0.9629889],"study_design_scores_gemma":[0.00008817951,0.00026364456,0.0026212854,0.008652428,0.0003220404,0.012166144,0.000074371244,0.00025512645,0.0012716312,0.0018339207,0.9724247,0.000026600126],"about_ca_topic_score_codex":0.00044642662,"about_ca_topic_score_gemma":0.0006858354,"teacher_disagreement_score":0.0013651099,"about_ca_system_score_codex":0.00029102582,"about_ca_system_score_gemma":0.0004376153,"threshold_uncertainty_score":0.0045666695},"labels":[],"label_agreement":null},{"id":"W4220775154","doi":"10.1053/j.seminhematol.2022.03.003","title":"Laboratory testing for VITT antibodies","year":2022,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital","funders":"Boehringer Ingelheim; Meso Scale Diagnostics; Bristol-Myers Squibb","keywords":"Platelet factor 4; Heparin-induced thrombocytopenia; Platelet activation; Platelet; Antibody; Heparin; Immunology; Immunoassay; Chemistry; Medicine; Biochemistry","score_opus":0.04303833125196141,"score_gpt":0.32399649002935965,"score_spread":0.28095815877739827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220775154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6317629,0.07452756,0.036115203,0.016407479,0.0018564105,0.002215936,0.008560742,0.0024487625,0.22610503],"genre_scores_gemma":[0.96139216,0.007943967,0.0067386185,0.0071326434,0.0005666141,0.00027388448,0.0035068966,0.00006185584,0.012383417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985176,0.00031533587,0.0001620148,0.00022000729,0.0005653928,0.00021962827],"domain_scores_gemma":[0.99834657,0.00034267336,0.00031273678,0.00011955184,0.00064387586,0.00023458735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010578986,0.0007695019,0.00069262914,0.0019718776,0.00047815344,0.0007666916,0.00078622653,0.0010491322,0.0066772155],"category_scores_gemma":[0.0034437876,0.00018587116,0.00062816375,0.0010174322,0.00034300442,0.0005726435,0.00047196483,0.0009797175,0.0020700742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012266964,0.0012198776,0.67401886,0.0010227521,0.00038933186,0.04520286,0.000837648,0.00090408063,0.036121357,0.004307469,0.06903228,0.16571684],"study_design_scores_gemma":[0.00027548108,0.0035725087,0.5503138,0.0026569692,0.00054168084,0.24191818,0.0011746682,0.005258797,0.02813358,0.0048390324,0.1611559,0.00015950634],"about_ca_topic_score_codex":0.0026329348,"about_ca_topic_score_gemma":0.00107727,"teacher_disagreement_score":0.0066772155,"about_ca_system_score_codex":0.00054868317,"about_ca_system_score_gemma":0.0006047333,"threshold_uncertainty_score":0.022337496},"labels":[],"label_agreement":null},{"id":"W4221044867","doi":"10.1053/j.seminhematol.2022.03.004","title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT)","year":2022,"lang":"en","type":"editorial","venue":"Seminars in Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital; Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Immunology; Medicine; Immune thrombocytopenia; Immune system; Thrombotic thrombocytopenic purpura; Platelet; Hematology; Virology","score_opus":0.02000482823139426,"score_gpt":0.3148598754194279,"score_spread":0.2948550471880336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221044867","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009158479,0.013193779,0.0001518856,0.02845601,0.9565293,0.00002569935,0.00005326852,0.00005638578,0.0014420733],"genre_scores_gemma":[0.0007099895,0.007303137,0.00009251292,0.01823847,0.96941817,0.000022713552,0.00003848202,0.000019428302,0.0041570575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997338,0.00056173414,0.00045482154,0.00033046052,0.0010542704,0.00026068435],"domain_scores_gemma":[0.9913322,0.0040072445,0.00078096834,0.00023693166,0.0022073607,0.0014351937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051135956,0.004584008,0.0043780594,0.0030662185,0.0023895386,0.00543682,0.0035351892,0.02359312,0.009043548],"category_scores_gemma":[0.011902465,0.0017488353,0.0035307591,0.00134247,0.0018627997,0.0030026995,0.0015074427,0.02122012,0.006748559],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011240021,0.00003502184,0.00009180525,0.00050613703,0.000067298235,0.000601097,0.000010820875,0.000053515876,0.00008292576,0.0002693226,0.9894862,0.008683504],"study_design_scores_gemma":[0.00047521375,0.00015342634,0.0012167925,0.0012297956,0.00037936788,0.0020035352,0.00005272049,0.00064544094,0.0003249244,0.0009724411,0.9925052,0.0000412116],"about_ca_topic_score_codex":0.0017236228,"about_ca_topic_score_gemma":0.0037594282,"teacher_disagreement_score":0.02359312,"about_ca_system_score_codex":0.00329579,"about_ca_system_score_gemma":0.0018001092,"threshold_uncertainty_score":0.030253649},"labels":[],"label_agreement":null},{"id":"W4248000555","doi":"10.1053/shem.2002.34091","title":"Pentasaccharides","year":2002,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Fondaparinux; Antithrombotic; Venous thrombosis; Thrombosis; Clinical trial; Enoxaparin sodium; Intensive care medicine; Internal medicine; Venous thromboembolism; Low molecular weight heparin","score_opus":0.062030709480772196,"score_gpt":0.3626355583279039,"score_spread":0.3006048488471317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248000555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048647206,0.98358065,0.0019864268,0.00033774824,0.0010502917,0.00004786407,0.00011935581,0.00007200161,0.007940889],"genre_scores_gemma":[0.014348754,0.9739285,0.0017563994,0.00045884162,0.00036872405,0.000039318675,0.00031229793,0.00001250219,0.008774551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992,0.000012094294,0.000012897536,0.000013674251,0.000027818509,0.000013535437],"domain_scores_gemma":[0.99994135,0.000011970004,0.000019127521,0.0000063813973,0.0000110612855,0.0000101448895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012454655,0.0012794287,0.00088517426,0.0011681452,0.00016935682,0.0007313919,0.00035283063,0.00052359473,0.0038948671],"category_scores_gemma":[0.00022689816,0.0001863009,0.0002631224,0.0015171871,0.00024525862,0.0007526636,0.00070139725,0.0006189487,0.0042019347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002443483,0.000087450906,0.00020791497,0.0038169618,0.00006225248,0.0006583211,0.00002871382,0.0002708582,0.018494783,0.0008805899,0.0113684125,0.9638794],"study_design_scores_gemma":[0.000049168237,0.0003839284,0.001525321,0.0015941353,0.00018092495,0.004653358,0.000058170575,0.00013881632,0.021696046,0.0011516194,0.96853995,0.000028561148],"about_ca_topic_score_codex":0.00035278147,"about_ca_topic_score_gemma":0.00042061208,"teacher_disagreement_score":0.0038948671,"about_ca_system_score_codex":0.00021507774,"about_ca_system_score_gemma":0.00050631125,"threshold_uncertainty_score":0.013029635},"labels":[],"label_agreement":null},{"id":"W4254260923","doi":"10.1053/j.seminhematol.2006.03.004","title":"Inhibitor Economics","year":2006,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Dosing; Medicine; Intensive care medicine; Clotting factor; Internal medicine","score_opus":0.053325441308043814,"score_gpt":0.37656217605011555,"score_spread":0.3232367347420717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254260923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006685494,0.9405585,0.0021905152,0.0038080807,0.0017713215,0.00006014397,0.00022033133,0.00007254989,0.05065007],"genre_scores_gemma":[0.015901316,0.92502904,0.0021076824,0.0039366772,0.002591323,0.00010501221,0.00044234947,0.000025109388,0.04986161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995505,0.00011381014,0.000038544076,0.000055026696,0.00018112987,0.000061007304],"domain_scores_gemma":[0.99959916,0.00015588854,0.00009532993,0.000028047481,0.00007666289,0.000044960554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007059954,0.0007926928,0.001066582,0.0019354047,0.00037136508,0.0013530169,0.001009321,0.001331696,0.045020208],"category_scores_gemma":[0.0022016533,0.00024171281,0.00053004554,0.0015577622,0.00049733813,0.0011319246,0.0007597592,0.0015662281,0.009315451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003135278,0.00011438174,0.00034885973,0.0038928771,0.00011995932,0.00026218846,0.000015447396,0.00029105047,0.00029824677,0.016073855,0.15033731,0.82793224],"study_design_scores_gemma":[0.00015299114,0.00006817456,0.0007530682,0.002678817,0.00016606049,0.0016811478,0.000015303789,0.0001263118,0.00032937477,0.00552096,0.9884986,0.000009112359],"about_ca_topic_score_codex":0.0013875511,"about_ca_topic_score_gemma":0.0019159293,"teacher_disagreement_score":0.045020208,"about_ca_system_score_codex":0.001102399,"about_ca_system_score_gemma":0.0019814945,"threshold_uncertainty_score":0.15060753},"labels":[],"label_agreement":null},{"id":"W4389242340","doi":"10.1053/j.seminhematol.2023.11.006","title":"Biological heterogeneity in diffuse large B-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"Michael Smith Health Research BC","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Biology; Precision medicine; Computational biology; Oncology; Medicine; Bioinformatics; Immunology; Genetics","score_opus":0.02726806348528607,"score_gpt":0.3029398652008562,"score_spread":0.27567180171557015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12290132,0.8617592,0.0045974813,0.0036950593,0.00019131215,0.0000332302,0.0002573071,0.00006147019,0.0065037077],"genre_scores_gemma":[0.6882095,0.30425763,0.0028596262,0.001815385,0.0009413549,0.000040754254,0.0005376815,0.000022705517,0.001315376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999721,0.00009915531,0.000026675432,0.000045531364,0.00007672651,0.000030835483],"domain_scores_gemma":[0.99979025,0.00010210095,0.000054632255,0.000007803868,0.000025689957,0.000019515504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000664479,0.00014062379,0.00037834654,0.0008697987,0.00012769243,0.00081828795,0.00019480553,0.0002844241,0.00035761783],"category_scores_gemma":[0.0008408288,0.00008578598,0.00017581563,0.0006882544,0.0003656379,0.0004490108,0.00045268962,0.0003657828,0.00016868186],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004588865,0.00003161456,0.09380419,0.0025578677,0.00033146137,0.006213607,0.00081451284,0.0012902924,0.041287534,0.010420442,0.012292604,0.830497],"study_design_scores_gemma":[0.00009466273,0.00048003334,0.27900782,0.0023037228,0.00092418876,0.09602181,0.00254796,0.0025673122,0.015699608,0.038505767,0.5617238,0.00012336156],"about_ca_topic_score_codex":0.0005713816,"about_ca_topic_score_gemma":0.0007309588,"teacher_disagreement_score":0.0008697987,"about_ca_system_score_codex":0.00055962586,"about_ca_system_score_gemma":0.00025425505,"threshold_uncertainty_score":0.0040603876},"labels":[],"label_agreement":null},{"id":"W4391111985","doi":"10.1053/j.seminhematol.2024.01.008","title":"Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities","year":2023,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Genentech; Roche","keywords":"Rituximab; Prednisone; Medicine; Cyclophosphamide; Vincristine; Internal medicine; Lymphoma; Oncology; Diffuse large B-cell lymphoma; Malignancy; Intensive care medicine; Chemotherapy","score_opus":0.014019188564911892,"score_gpt":0.2852982883684454,"score_spread":0.2712790998035335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391111985","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19397788,0.123780556,0.008276367,0.46171555,0.023927959,0.00033172872,0.0013980314,0.0010768074,0.18551503],"genre_scores_gemma":[0.60387146,0.054687988,0.014688419,0.23681982,0.012835225,0.00030739707,0.0022908156,0.0002621553,0.07423675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977404,0.000044930395,0.000009880427,0.000025591242,0.000039197956,0.000106364794],"domain_scores_gemma":[0.99918777,0.000084967185,0.00010474871,0.000014329246,0.00009404131,0.00051410473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028790344,0.00022514656,0.00048247477,0.00029929515,0.0010491597,0.001098244,0.00033446698,0.0014049694,0.016810179],"category_scores_gemma":[0.0012713815,0.00010626985,0.00060448464,0.00016760816,0.00031134102,0.0011175601,0.00061868096,0.0029731279,0.0040011276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007321747,0.0010397957,0.074586555,0.0010696854,0.00015506458,0.002620091,0.0010061644,0.0002733806,0.005991452,0.002771028,0.34797418,0.5617804],"study_design_scores_gemma":[0.0003686152,0.0020896913,0.09360016,0.002568279,0.0005360129,0.012181817,0.0049782633,0.00039104346,0.0043306225,0.009635393,0.8691999,0.00012028439],"about_ca_topic_score_codex":0.0012002839,"about_ca_topic_score_gemma":0.0036102368,"teacher_disagreement_score":0.016810179,"about_ca_system_score_codex":0.00052368804,"about_ca_system_score_gemma":0.0010277776,"threshold_uncertainty_score":0.05623567},"labels":[],"label_agreement":null},{"id":"W4399208036","doi":"10.1053/j.seminhematol.2024.05.005","title":"Molecular biomarkers in classic Hodgkin lymphoma","year":2024,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"BC Cancer Foundation; Gilead Research Scholars; Gilead Sciences","keywords":"Medicine; Lymphoma; Biomarker; Malignancy; Clinical trial; Disease; Immunotherapy; Population; Oncology; Cancer; Internal medicine; Biology","score_opus":0.02873641042350275,"score_gpt":0.35066815653789835,"score_spread":0.32193174611439557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399208036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003777097,0.9992086,0.0000593801,0.00019060799,0.0002164088,0.0000024491032,0.0000111446525,0.0000050233266,0.00026860303],"genre_scores_gemma":[0.00057098916,0.998151,0.00015075135,0.00039078586,0.00038393907,0.000005106422,0.000033486293,0.0000011954837,0.00031275125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997359,0.00005437573,0.000054677595,0.000042807183,0.00008448699,0.000027718586],"domain_scores_gemma":[0.99937785,0.0003374153,0.00010792419,0.000017394228,0.00011923127,0.000040145744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088426255,0.0010240849,0.0019196403,0.0025628447,0.00018395831,0.001389004,0.0008606017,0.0011649383,0.0029599285],"category_scores_gemma":[0.0016796163,0.0004022501,0.0007089769,0.0020612492,0.0005159363,0.0014909663,0.00086832186,0.0021979108,0.0016932847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013046658,0.000045597215,0.0002717039,0.014772794,0.000154996,0.00019653028,0.000030047344,0.0003019985,0.000722224,0.0014213205,0.043054562,0.93889785],"study_design_scores_gemma":[0.00010914019,0.00014936301,0.0017276705,0.011782296,0.0007082627,0.0018290898,0.0000566925,0.00019934913,0.00054710737,0.0025617732,0.9802915,0.00003789942],"about_ca_topic_score_codex":0.0009053106,"about_ca_topic_score_gemma":0.0016502371,"teacher_disagreement_score":0.0029599285,"about_ca_system_score_codex":0.00067352905,"about_ca_system_score_gemma":0.0011372648,"threshold_uncertainty_score":0.009902},"labels":[],"label_agreement":null},{"id":"W4402700985","doi":"10.1053/j.seminhematol.2024.09.006","title":"Cellular and immunotherapies for myelodysplastic syndromes","year":2024,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Immunology; Immunotherapy; Bone marrow; Immune system","score_opus":0.026158966748613857,"score_gpt":0.30234355311383015,"score_spread":0.2761845863652163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402700985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010590887,0.9988902,0.00014885618,0.0001404367,0.00025937962,0.0000052708706,0.000009671048,0.00000585976,0.00043439175],"genre_scores_gemma":[0.0015080845,0.9963916,0.00031306548,0.0003835307,0.00047862902,0.000016429807,0.00003937613,0.0000024280303,0.0008669517],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998641,0.000031606767,0.000020371552,0.00002115157,0.00004507049,0.000017726577],"domain_scores_gemma":[0.999828,0.000097604294,0.000028630715,0.000005553012,0.00002569203,0.000014465667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055746734,0.000999098,0.0015210529,0.0014238341,0.00017775735,0.0005773927,0.0007796104,0.0010038414,0.002992076],"category_scores_gemma":[0.0005252077,0.00019080316,0.0004931662,0.0010583461,0.00039312016,0.0006474646,0.0005213529,0.0019007408,0.0013714],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016182385,0.000099211546,0.000061071245,0.007934926,0.00008676664,0.00017380464,0.000023284318,0.00032829784,0.0023243565,0.0014913281,0.027841466,0.95947367],"study_design_scores_gemma":[0.00020362365,0.00053233013,0.0011411232,0.0035963259,0.00036204472,0.0025420757,0.00003406,0.00020158867,0.0013417008,0.0015402344,0.98848164,0.000023274863],"about_ca_topic_score_codex":0.00041296263,"about_ca_topic_score_gemma":0.0009919041,"teacher_disagreement_score":0.002992076,"about_ca_system_score_codex":0.00038023273,"about_ca_system_score_gemma":0.00044662095,"threshold_uncertainty_score":0.010009468},"labels":[],"label_agreement":null},{"id":"W4409252656","doi":"10.1053/j.seminhematol.2025.04.004","title":"Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors","year":2025,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Pharmacyclics; BeiGene; Eli Lilly and Company","keywords":"Waldenstrom macroglobulinemia; Medicine; Macroglobulinemia; Ibrutinib; Bruton's tyrosine kinase; Intensive care medicine; Internal medicine; Immunology; Lymphoma; Chronic lymphocytic leukemia; Leukemia; Multiple myeloma","score_opus":0.020679086787591852,"score_gpt":0.3092122550952038,"score_spread":0.28853316830761194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409252656","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046609864,0.03302108,0.010409563,0.79683113,0.11021487,0.0044473745,0.0040206565,0.00028279237,0.03611149],"genre_scores_gemma":[0.044764664,0.05073308,0.04093409,0.7231586,0.055053703,0.010655735,0.015250264,0.00050314236,0.058946714],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9759842,0.009850567,0.0038990674,0.0018804378,0.0051974156,0.0031882315],"domain_scores_gemma":[0.943847,0.009207635,0.004790021,0.0012026004,0.029423723,0.011528994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04849732,0.0017107577,0.002331932,0.0017864957,0.0029224283,0.004505173,0.006303988,0.021254746,0.0130735785],"category_scores_gemma":[0.042752143,0.0012738524,0.0047633876,0.0015087525,0.0013887031,0.002966361,0.0063763396,0.016274408,0.0071016885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018682292,0.00010709508,0.0015129021,0.001706255,0.00012126797,0.0004712172,0.00049303146,0.00046580733,0.0010066655,0.0024016374,0.93944335,0.052084025],"study_design_scores_gemma":[0.0002456442,0.00012065603,0.0032670936,0.006270783,0.00017892192,0.00036518386,0.00075115246,0.00033476818,0.0005523225,0.0024737634,0.98535603,0.00008355024],"about_ca_topic_score_codex":0.0074688396,"about_ca_topic_score_gemma":0.009376224,"teacher_disagreement_score":0.04849732,"about_ca_system_score_codex":0.006371348,"about_ca_system_score_gemma":0.0270106,"threshold_uncertainty_score":0.2564814},"labels":[],"label_agreement":null},{"id":"W4409259280","doi":"10.1053/j.seminhematol.2025.04.001","title":"Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease","year":2025,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Macroglobulinemia; Medicine; Waldenstrom macroglobulinemia; Consensus conference; Intensive care medicine; Pediatrics; Internal medicine; Multiple myeloma; Lymphoma","score_opus":0.014322791936131797,"score_gpt":0.2883078627752115,"score_spread":0.2739850708390797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409259280","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073014554,0.037778925,0.006956495,0.82539123,0.09324354,0.0025119167,0.00568184,0.0001284076,0.02100618],"genre_scores_gemma":[0.082825564,0.07852749,0.042077757,0.67805165,0.057367444,0.009258426,0.023442043,0.00050165027,0.027948076],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9742606,0.0098040365,0.0041254717,0.0019486995,0.0071597667,0.002701519],"domain_scores_gemma":[0.9158905,0.020663906,0.0070057497,0.0019107634,0.039912388,0.014616791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06810345,0.0017415067,0.0028550173,0.0017006495,0.0031262392,0.004430683,0.005944582,0.020505706,0.0051346007],"category_scores_gemma":[0.058754057,0.0011423663,0.0044114282,0.0018629399,0.001164454,0.0022088764,0.0041077617,0.02139509,0.0022271166],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068626355,0.00029196258,0.00611878,0.0030694008,0.0005724729,0.0007494055,0.00097121974,0.0007911382,0.0015361236,0.0023682383,0.908704,0.07414102],"study_design_scores_gemma":[0.0012388463,0.00030991147,0.02220964,0.017220294,0.0015126762,0.00065972726,0.002135267,0.0007028556,0.0018328459,0.004182008,0.9477908,0.00020505632],"about_ca_topic_score_codex":0.017103849,"about_ca_topic_score_gemma":0.028036807,"teacher_disagreement_score":0.06810345,"about_ca_system_score_codex":0.0067193476,"about_ca_system_score_gemma":0.029319387,"threshold_uncertainty_score":0.36016977},"labels":[],"label_agreement":null},{"id":"W4410022474","doi":"10.1053/j.seminhematol.2025.04.006","title":"Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy","year":2025,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Waldenstrom macroglobulinemia; Macroglobulinemia; Medicine; Intensive care medicine; Immunology; Family medicine; Multiple myeloma; Lymphoma","score_opus":0.010020231422262504,"score_gpt":0.24753134877133498,"score_spread":0.2375111173490725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410022474","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019253323,0.07023107,0.01116969,0.76335096,0.08649429,0.003759468,0.0062710317,0.00017716104,0.039293017],"genre_scores_gemma":[0.20971005,0.11427546,0.06348334,0.4800921,0.057804216,0.009601626,0.031511642,0.00050020055,0.033021417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98522264,0.005752888,0.002969846,0.001212472,0.003308171,0.0015340016],"domain_scores_gemma":[0.9567174,0.008060271,0.0035976805,0.0008435209,0.024257496,0.0065235947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037001096,0.001479213,0.002306549,0.001682088,0.002626836,0.0033140888,0.0045102937,0.012760011,0.0042874957],"category_scores_gemma":[0.03779167,0.0008321208,0.0030205243,0.0015616987,0.0007832794,0.0019102141,0.002969571,0.013004262,0.0017161929],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068748725,0.000399095,0.014833313,0.0038973459,0.0006379421,0.0019630597,0.001366907,0.0011838702,0.0025654084,0.0024166445,0.83839095,0.13165802],"study_design_scores_gemma":[0.0013787642,0.000445696,0.03708696,0.021376349,0.0013466225,0.0023276713,0.0031234291,0.0011638585,0.0022969546,0.0042531346,0.9249753,0.00022535716],"about_ca_topic_score_codex":0.012282093,"about_ca_topic_score_gemma":0.018859364,"teacher_disagreement_score":0.037001096,"about_ca_system_score_codex":0.004603579,"about_ca_system_score_gemma":0.015434317,"threshold_uncertainty_score":0.19568282},"labels":[],"label_agreement":null},{"id":"W7139921962","doi":"10.1053/j.seminhematol.2026.03.009","title":"Role of MRD testing in acute myeloid leukemias. What is the status and how to get there?","year":2025,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institutes of Health","keywords":"Hematology; Myeloid; Myeloid leukemia; MEDLINE; Clinical trial","score_opus":0.014233997498073733,"score_gpt":0.30098124163059625,"score_spread":0.2867472441325225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7139921962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033562726,0.6474169,0.002139148,0.32526758,0.010443063,0.000076439814,0.00032716172,0.00019783727,0.010775538],"genre_scores_gemma":[0.10035855,0.69193506,0.0103030475,0.12425552,0.06517823,0.00027666075,0.0007433399,0.00025363112,0.006695947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920014,0.0037325423,0.0011330732,0.0007200858,0.0018958675,0.00051699113],"domain_scores_gemma":[0.93271685,0.03898448,0.0035599482,0.0018367209,0.016753448,0.0061485786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027041828,0.001251238,0.0036216835,0.0021769125,0.0015810333,0.00813424,0.002573513,0.0058072573,0.007319601],"category_scores_gemma":[0.061211362,0.00090181053,0.0018051577,0.0012226542,0.003846227,0.012902556,0.002657081,0.011233455,0.004087464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007870244,0.00021744671,0.01680627,0.0026733973,0.00029438868,0.0005501636,0.0005166071,0.00061991136,0.00061531394,0.005845485,0.1665393,0.8045347],"study_design_scores_gemma":[0.00106236,0.0020040276,0.058825947,0.047421116,0.0017306707,0.007905907,0.0045359144,0.0036749372,0.0011452046,0.047941323,0.82310027,0.0006524059],"about_ca_topic_score_codex":0.0073975218,"about_ca_topic_score_gemma":0.010792322,"teacher_disagreement_score":0.027041828,"about_ca_system_score_codex":0.0028272322,"about_ca_system_score_gemma":0.005970177,"threshold_uncertainty_score":0.14301252},"labels":[],"label_agreement":null}]}